Literature DB >> 33194715

Sustained Exposure to Helicobacter pylori Lysate Inhibits Apoptosis and Autophagy of Gastric Epithelial Cells.

Yang He1, Cunlong Wang1, Xiulin Zhang1, Xuancheng Lu2, Jin Xing3, Jianyi Lv1, Meng Guo1, Xueyun Huo1, Xin Liu1, Jing Lu1, Xiaoyan Du1, Changlong Li1, Zhenwen Chen1.   

Abstract

Helicobacter pylori is designated as a class I carcinogen of human gastric cancer following long-term infection. During this process, H. pylori bacteria persist in proliferation and death, and release bacterial components that come into contact with gastric epithelial cells and regulate host cell function. However, the impact of long-term exposure to H. pylori lysate on the pathological changes of gastric cells is not clear. In this study, we aimed to investigate the regulation and mechanisms involved in gastric cell dysfunction following continuous exposure to H. pylori lysate. We co-cultured gastric cell lines GES-1 and MKN-45 with H. pylori lysate for 30 generations, and we found that sustained exposure to H. pylori lysate inhibited GES-1 cell invasion, migration, autophagy, and apoptosis, while it did not inhibit MKN-45 cell invasion or migration. Furthermore, Mongolian gerbils infected with H. pylori ATCC 43504 strains for 90 weeks confirmed the in vitro results. The clinical and in vitro data indicated that sustained exposure to H. pylori lysate inhibited cell apoptosis and autophagy through the Nod1-NF-κB/MAPK-ERK/FOXO4 signaling pathway. In conclusion, sustained exposure to H. pylori lysate promoted proliferation of gastric epithelial cells and inhibited autophagy and apoptosis via Nod1-NF-κB/MAPK-ERK/FOXO4 signaling pathway. In the process of H. pylori-induced gastric lesions, H. pylori lysate plays as an "accomplice" to carcinogenesis.
Copyright © 2020 He, Wang, Zhang, Lu, Xing, Lv, Guo, Huo, Liu, Lu, Du, Li and Chen.

Entities:  

Keywords:  Helicobacter pylori; apoptosis; autophagy; carcinogenesis; gastric epithelial cell

Year:  2020        PMID: 33194715      PMCID: PMC7658535          DOI: 10.3389/fonc.2020.581364

Source DB:  PubMed          Journal:  Front Oncol        ISSN: 2234-943X            Impact factor:   6.244


Introduction

Helicobacter pylori (H. pylori) is designated as a class I carcinogen of human gastric cancer (1), and it can survive for prolonged periods in the acidic gastric environment. H. pylori infection is closely related to gastritis, peptic ulcer, gastric cancer, gastric mucosa-associated lymphoid tissue (MALT) lymphoma, and even some extragastric diseases (2–5). It is generally believed that the diseases induced by H. pylori infection are caused by living bacteria. H. pylori induces defective autophagy or inhibits autophagy to promote its own colonization (6, 7). Moreover, H. pylori is involved in migration, invasion, autophagy, and apoptosis, eventually leading to gastric cancer (8, 9). H. pylori promotes the malignant transformation of the host cells by transporting cytotoxin-associated gene product A (CagA), an oncoprotein, to cells through the type IV secretion system (T4SS) (10–12). Furthermore, H. pylori secretes vacuolating cytotoxin A (VacA) (13) and destroys the activity of lysosomal calcium channels in host cells, which leads to the formation of dysfunctional enlarged lysosomes and allows H. pylori to colonize in the stomach and, thus, escape from eradication therapy (14). In addition, the outer membrane vesicles (OMVs) released by H. pylori contain a variety of bacterial toxins and antigens (15), which are absorbed by gastric epithelial cells (16) and enhance the carcinogenic potential of H. pylori (17). During long-term infection by H. pylori, a large number of bacteria persist in proliferation and death. Massive bacterial compositions maintain contact with and stimulate gastric epithelial cells. These bacterial components enter the host cell in multiple ways, such as receptor recognition and OMVs, regulate cell survival and metabolism, and lead to pathological diseases of the gastric mucosal barrier (18–20). During bacterial disintegration in the stomach, various components act on endothelial cells simultaneously. It has been reported that H. pylori lysate promotes hepatocellular carcinoma (HSC) cell proliferation and liver fibrosis (21). Further, Helicobacter suis lysate regulates the apoptosis of gastric epithelial cells (22). To date, most reports have investigated the mechanisms of H. pylori-induced gastric diseases by infecting living bacteria or a single bacterial virulence factor to cell lines for 6 h to 72 h (8, 18, 21, 22). However, these cannot simulate the effects of long-term stimulation of H. pylori on gastric cells. Because H. pylori cannot survive co-cultures with cells for an extended time, long-term co-cultures with gastric epithelial cells using H. pylori lysate instead of living bacteria are used to simulate the regulatory effects of persistent infection on cells. In this process, the effects of H. pylori lysate are also important. In this study, H. pylori lysate was prepared by ultrasonic lysis and was co-cultured with gastric epithelial cells for 30 consecutive generations to investigate the underlying mechanisms involved in its cellular regulatory activity in vitro and in vivo. Our data demonstrate that sustained exposure of gastric epithelial cells to H. pylori lysate promoted proliferation and inhibited autophagy and apoptosis, and it may further lead to malignant transformation in gastric epithelial cells.

Materials and Methods

Bacterial Culture and Preparation of Bacterial Lysate

The H. pylori strain American Type Culture Collection (ATCC) 43504 (cagA+, vacA+) was obtained from the National Institutes for Food and Drug Control, Beijing. H. pylori was grown on Colombian agar plates (OXOID, UK, CM0331B) containing 5% sterile and defibrated sheep blood (MRC, China, CCS30037.01) at 37°C under microaerophilic conditions for 48 h. H. pylori was scraped off the plate and washed twice with phosphate buffer saline (PBS) (KeyGen BioTECH, China, KGB5001), then mixed with PBS, and ultrasonic lysis was performed. We used the bicinchoninic acid (BCA) method to detect protein concentration. The lysate was stored at -20°C until use.

Cell Lines and Cell Culture

The human normal gastric epithelial cell line GES-1 and human gastric adenocarcinoma cell line MKN-45 were purchased from Beijing Dingguo Changsheng Biotechnology Co., Ltd. Cells were grown in DMEM (Corning, USA, 10-013-CVR) supplemented with 10% fetal bovine serum (FBS) (PAN, Germany, P30-3302) and 1% penicillin/streptomycin binary antibody solution (KeyGen BioTECH, China, KGY0023) in a humidified environment and under 5% CO2 at 37°C. GES-1 cells and MKN-45 cells of the experimental group were cultured in medium added with H. pylori lysate for 30 consecutive generations. The other conditions were consistent with those of the control group. The untreated normal cells were labeled as B-GES-1 and B-MKN-45, which were cultured for 30 consecutive generations. The cells co-cultured with H. pylori lysate for 30 generations were labeled as Cul30-GES-1 and Cul30-MKN-45, respectively.

Cell Treatment

A total of 4×105 Cul30-GES-1 and B-GES-1, Cul30-MKN-45, and B-MKN-45 cells were seeded into 6-well plates. After the cells were attached, normal DMEM, DMEM containing H. pylori lysate, or DMEM containing H. pylori (6×106 CFU/mL) (23) was separately added to the 6-well plates for a total of 2 mL per well, and cells were incubated for 24 h.

Determining the Optimum Concentration of H. pylori Lysate to Be Co-Cultured With Cells

The optimum concentration of H. pylori lysate to be co-cultured with cells was determined by MTT. B-GES-1 or B-MKN-45 cells were digested with 0.25% trypsin and washed with PBS. The cell suspension concentration was adjusted to 2.5×104/mL using DMEM medium containing 10% FBS. The cells were inoculated in 96-well plates with a volume of 100 μL per well. The edge wells of the 96-well plate were filled with 200 μL sterile PBS solution, and the culture was continued for 6 h to allow the cells to adhere. After the cells were attached, the medium was discarded, and the cells were washed twice with PBS solution. In the experimental group, medium containing different concentrations of H. pylori lysate was added (0.5 μg/mL, 1 μg/mL, 1.5 μg/mL, 2 μg/mL, 2.5 μg/mL, 3 μg/mL, 3.5 μg/mL, 4 μg/mL, 4.5 μg/mL, 5 μg/mL), in a volume of 200 μL per well, and the control group received 200 μL of normal medium containing an equal amount of PBS solution. Five sub-wells were set for each experimental group and control group. The cells were cultured for another 72 h. After 72 h of culture, the culture medium was discarded. Cells were washed twice with PBS solution. Sterile MTT solution (Solarbio, China, M1020) was added to the well in a final volume of 100 μL. The cells were cultured for 4 h. The solution in the 96-well plate was discarded and 100 μL dimethyl sulfoxide (DMSO) was added to each well. The plate was placed on a shaking table for 10 min to dissolve the methylamine precipitate. Absorbance of each well was read at 490 nm using a microplate reader of a spectrophotometer to measure the cell quantity.

Cell Proliferation Assay

In this study, gastric cells were co-cultured with H. pylori or H. pylori lysate. The cell proliferation of Cul30-GES-1 and B-GES-1, Cul30-MKN-45, and B-MKN-45 were compared by two methods. First, the cells were plated into 96-well plates and then cultured in medium containing H. pylori lysate or H. pylori for 24 h or 48 h. Then MTT colorimetric assay was carried out. Second, plate cloning assay was used. Cul30-GES-1 and B-GES-1 (500 cells/well) were placed in 6-well plates and maintained in DMEM medium containing 10% FBS. After 14 days, the cells were fixed and stained by crystal violet. Visible colonies were then counted by Image J software. Each well was assessed in triplicate.

Wound Healing Assay

B-GES-1 and Cul30-GES-1 were placed in 6-well plates and maintained in DMEM medium containing 10% FBS. The cell concentration was 5×105 cells/mL and 2 mL volume was added per well. When cells reached 90% confluence, a wound was generated, the medium was discarded, and the cells were washed twice with PBS solution to remove any floating cells. In the experimental group, serum free medium containing H. pylori lysate or H. pylori was added at a volume of 2 mL per well, and the control group received 2 mL of serum free medium. The cells were incubated for 24 h. The gap distances were measured to assess the capacity of the cells to migrate.

Transwell Cell Migration and Invasion Assay

Transwell migration chamber was used for the migration assay. After treatment with H. pylori lysate or H. pylori, Cul30-GES-1 and B-GES-1, Cul30-MKN-45, and B-MKN-45 cells (3×104 cells in 200 μL) were placed in the upper chamber in serum-free medium. Medium containing 10% FBS was added to the lower chamber. The cells, following a 24-h incubation, were fixed and stained with 0.1% crystal violet and counted. The assays were performed in triplicate. For the invasion assay, a total of 3×104 cells were seeded into the upper chamber of a Transwell invasion chamber with serum-free media, while medium containing 10% FBS was added to the lower chamber. The cells, after a 24-h incubation, were fixed and stained with Hoechst (Solarbio, China, B8040) for 10 min in a dark environment. The number of cells that invaded from the upper chamber were counted using Image J software.

Cytokine Level Analysis

Cul30-GES-1, B-GES-1 and Cul30-MKN-45, B-MKN-45 cells were treated with H. pylori lysate or H. pylori for 24 h. Cytokine level analysis was performed by Shanghai Universal Biotech Co., Ltd. The Luminex detection assays were used to measure the expression of each factor in the samples. According to previous reports, eight cytokines in Cul30-GES-1 and B-GES-1 cells related to autophagy, apoptosis, migration, or invasion were selected for detection, including TNF-α, CCL-20, CCL-28, CXCL-2, IFN-γ, TFPI, SLPI, and FAS. Three cytokines, CCL-20, CCL-28, and CXCL-2, in Cul30-MKN-45 and B-MKN-45 cells associated with migration and invasion were also detected.

mCherry-EGFP-LC3 Transfection

Two milliliters of Cul30-GES-1 and B-GES-1 cell suspension with a density of 2.5 × 104 cells/mL was prepared in complete medium and added to a 6-well plate. After the cells were attached, the old medium was discarded, the cells were washed with PBS, and medium containing a 50 μL titer of 108 TU/mL mCherry-EGFP-LC3 lentivirus (purchased from SyngenTech Co., Ltd) and 8 μg/mL Polybrene was added to the culture. After 48 h of infection, the fluorescence expression of cells was observed by fluorescence microscopy. When the efficiency of cell infection reached about 80%, the cells were cultured in medium containing H. pylori lysate or H. pylori for an additional 24 h. The images of mCherry-EGFP-LC3 transfected cells were observed by laser scanning confocal microscopy. The autophagy flux was measured by the color change of mCherry-EGFP.

Hoechst Staining

After treatment with H. pylori lysate or H. pylori, Cul30-GES-1 and B-GES-1 cells were washed with PBS three times. Next, cells were stained with Hoechst 33342 (10 μg/mL) for 10 min. Nuclear morphologic changes were examined under a fluorescence microscope.

Apoptosis Assay

Flow cytometry was used to detect the effects of H. pylori lysate on the apoptosis of Cul30-GES-1 and B-GES-1 cells using the Annexin V-PE/7-AAD Apoptosis Detection Kit (Vazyme, China, A213-01) according to the manufacturer’s recommendations. The rate of apoptosis was analyzed using LSR Fortessa Flow Cytometer at 488 nm.

Evaluation of Gene Expression via the TCGA Database

The gene mRNA expression data of 132 gastric adenocarcinoma cases (17 cases of H. pylori infection and 115 cases without H. pylori infection) were downloaded from the TCGA database (https://cancergenome.nih.gov/). Log2 transformation and Z-correction were performed to normalize the expression value of each gene.

Reverse Transcriptase Polymerase Chain Reaction

A TRIzol Reagent (Vazyme, China, R401-01) was used to isolate total RNA from Cul30-GES-1 and B-GES-1 cells. Single-stranded DNA was prepared from 1 μg total RNA using reverse transcriptase-bound oligonucleotide (DT) primers. Each cDNA sample (2 μL) was subjected to reverse transcriptase polymerase chain reaction (RT-PCR) amplification using specific primers as detailed in . The data were collected and analyzed. The values were compared with the experimental controls after being normalized to those of GAPDH.

Western Blot

Following treatment with H. pylori lysate or H. pylori, Cul30-GES-1 and B-GES-1, Cul30-MKN-45, and B-MKN-45 cells were lysed by Radio Immunoprecipitation Assay (RIPA) Lysis Buffer (Solarbio, China, R0010) on ice for 30 min. The cell lysate was centrifuged at 13400×g at 4°C for 15 min. The supernatants were collected, and the protein concentration was measured with a BCA protein kit (Thermo Scientific, USA, A53225). The lysate was mixed with PBS and 5× SDS loading buffer (ROBY, China, RBU114-2) and heated at 99°C for 10 min. Western blots were performed on 8% or 10% SDS-polyacrylamide gel electrophoresis (PAGE) gel, and protein samples were transferred onto polyvinylidene fluoride (PVDF) membranes (Merck Millipore, USA, ISEQ00010). PVDF membranes were blocked by 5% skim milk (BD, USA, 232100) and were incubated first with rabbit primary antibodies overnight at 4°C, followed by incubation with a secondary antibody (Solarbio, China, SE134, 1:5000 dilution for western blot) for another 1 h. GAPDH (CST, USA, 5174, 1:1000 dilution for western blot) served as a loading control. The primary antibodies used for western in this study were as follows: LC3B-II (CST, USA 2775, 1:1000 dilution), p62 (CST, USA, 39749, 1:1000 dilution), Caspase-3 (CST, USA, 9662, 1:1000 dilution), Nod1 (CST, USA, 3545S, 1:1000 dilution), RIP2 (Abcam, UK, ab8428, 1:1000 dilution), p-ERK1/2 (CST, USA, 4370S, 1:1000 dilution), ERK1/2 (CST, USA, 4695, 1:1000 dilution), FOXO4 (CST, USA, 9472, 1:1000 dilution), p-IKKA (Abcam, UK, ab38515, 1:1000 dilution), IKKA (Abcam, UK, ab32041, 1:1000 dilution), BCL-2 (Abcam, UK, ab32124, 1:1000 dilution), BNIP3 (Abcam, UK, ab109362, 1:1000 dilution).

Mongolian Gerbil H. pylori Infection Model

Five Mongolian gerbils weighing 60–80 g were used to establish the in vivo H. pylori model and five H. pylori-negative gerbils were used as controls. All gerbils were obtained from the Capital Medical University and were fed at secondary biosafety laboratories at the Chinese Center for Disease Control and Prevention. Gerbils were housed in standard plastic cages in a room with a 12-h light/dark cycle and free access to food and water throughout all experiments. Gerbils 6–8 weeks of age were infected with H. pylori ATCC 43504 strain solution by oral gavage with 0.5 mL 2×109 CFU/mL. Gerbils were fasted for 12 h prior to challenge, and oral gavage was performed 5 times at intervals of 48 h. Before animals were euthanized, the 13C urea breath test and PCR were performed to confirm that H. pylori had colonized the gerbils. Ninety weeks after infection, gerbils were euthanized and the stomach tissue samples and blood were collected. The animal experiments were conducted in accordance with the Guidelines of the CMU Animal Experiments and Experimental Animals Management Committee under a protocol approved by the Animal Experiments and Experimental Animal Welfare Committee of CMU (Permit number: AEEI-2016-154).

TUNEL Staining

TUNEL staining was performed using the TUNEL Bright Green Apoptosis Detection Assay kit (Vazyme, China, A112) to detect apoptotic cells in the gerbil’s stomach according to the manufacturer’s instructions. Briefly, paraffin sections were dewaxed, hydrated, and treated with proteinase K for 30 min and then incubated with a fluorescently labeled solution of dUTP and TdT enzyme for 80 min at 37°C. Positive controls were incubated with DNase I for 10 min at room temperature prior to the fluorescent labeling procedure, while negative controls were incubated with dUTP for 10 min. The nuclei were then counterstained with Hoechst and the samples were blocked by antifading mounting medium.

Immunohistochemistry

Stomach sections were incubated with rabbit monoclonal anti-LC3 antibody (Abcam, UK, ab128025, 1:100 dilution for immunohistochemistry) overnight at 4°C followed by incubation with corresponding biotinylated secondary antibody. The cell nuclei were counterstained with hematoxylin, and the samples were dehydrated in a gradient series, vitrified with dimethylbenzene, and finally mounted with neutral balsam.

ELISA Analysis

The levels of BCL-2 and BNIP3 in the gerbils’ sera were measured by ELISA using the Gerbil BCL-2 ELISA kit (Enzymatic Biotechnology, China) and Gerbil BNIP3 ELISA kit (Enzymatic Biotechnology, China) following the manufacturer’s instructions. A 47 μL volume of sample dilution solution and 3 μL sample were added to each sample well of the enzyme labeling plate. After mixing, 100 μL enzyme labeling reagent was added into each well and incubated at 37°C for 1 h. The plate was washed, and the color developer was added at 37°C in a dark environment. The reaction was terminated after 15 min. Finally, the absorbance of each well was measured at 450 nm wavelength in a microplate reader.

Statistical Analysis

All statistical analyses were carried out using SPSS v19.0 software. Data are expressed as the mean ± standard deviation. Independent sample t-test and one-way ANOVA analysis were used to determine the significance of the differences between the results. The Mann-Whitney U test was used to analyze gene expression from TCGA databases. Differences were considered statistically significant when the p-value was <0.05.

Results

Optimum Concentration of H. pylori Lysate Co-cultured With Gastric Epithelial Cells

To select a suitable concentration of H. pylori lysate for long-term co-culture with cells, we tested different concentrations of lysate for co-culture with gastric epithelial cells for 72 h. The MTT assay showed that the cell activity decreased as the concentration of H. pylori lysate increased. To ensure the stable growth of cells in long-term co-culture with H. pylori lysate, the concentration of lysate with 70%–80% activity of normal cells was chosen as the optimum concentration, which was determined to be 2 μg/mL for GES-1 cells and 1.5 μg/mL for MKN-45 cells ( ). GES-1 cells and MKN-45 cells of the experimental group were cultured in medium with H. pylori lysate for 30 consecutive generations using the optimum concentration determined above, and they were labeled as Cul30-GES-1 and Cul30-MKN-45, respectively. The untreated normal cells were labeled as B-GES-1 and B-MKN-45.
Figure 1

Sustained exposure to H. pylori lysate promotes proliferation of GES-1 and MKN-45 cells. GES-1 (A) and MKN-45 (B) cells were co-cultured with H. pylori lysate at a concentration of 0–5 μg/mL for 72 h, respectively. The concentration of H. pylori lysate exhibiting 70%–80% activity of normal cell activity was determined as the long-term co-culture concentration. Cul30-GES-1, B-GES-1, Cul30-MKN-45, and B-MKN-45 cells (n = 5 experiments) were challenged with H. pylori lysate (2 μg/mL for GES-1 cells and 1.5 μg/mL for MKN-45 cells) (C, D) or H. pylori (6×106 CFU/mL) (E, F) for 24 h or 48 h, respectively. Cell viability was detected by the MTT assay. n = 5. (G, H) The proliferation of Cul30-GES-1 and B-GES-1 cells was detected by the plate cloning assay. Image J software was used to count the visible colonies (n = 3 experiments). *p < 0.05, **p < 0.01.

Sustained exposure to H. pylori lysate promotes proliferation of GES-1 and MKN-45 cells. GES-1 (A) and MKN-45 (B) cells were co-cultured with H. pylori lysate at a concentration of 0–5 μg/mL for 72 h, respectively. The concentration of H. pylori lysate exhibiting 70%–80% activity of normal cell activity was determined as the long-term co-culture concentration. Cul30-GES-1, B-GES-1, Cul30-MKN-45, and B-MKN-45 cells (n = 5 experiments) were challenged with H. pylori lysate (2 μg/mL for GES-1 cells and 1.5 μg/mL for MKN-45 cells) (C, D) or H. pylori (6×106 CFU/mL) (E, F) for 24 h or 48 h, respectively. Cell viability was detected by the MTT assay. n = 5. (G, H) The proliferation of Cul30-GES-1 and B-GES-1 cells was detected by the plate cloning assay. Image J software was used to count the visible colonies (n = 3 experiments). *p < 0.05, **p < 0.01.

Sustained Exposure to H. pylori Lysate Promoted Proliferation of GES-1 and MKN-45 Cells

To study the regulation of H. pylori lysate on cell growth, Cul30-GES-1, B-GES-1, Cul30-MKN-45, and B-MKN-45 cells were cultured with H. pylori lysate (2 μg/mL for GES-1 cells and 1.5 μg/mL for MKN-45 cells) or H. pylori (6×106 CFU/mL) (23) for 24 h or 48 h, respectively. The results of the MTT assay showed that the activities of Cul30-GES-1 and Cul30-MKN-45 cells treated with H. pylori lysate or H. pylori exceeded those of B-GES-1 and B-MKN-45 cells ( ), which was further verified by the colony formation assay of GES-1 cells ( ). These data indicated that long-term treatment of H. pylori lysate promoted the proliferation of GES-1 and MKN-45 cells. Meanwhile, the cells still maintained strong activity under long-term exposure to H. pylori lysate.

Sustained Exposure to H. pylori Lysate Alters Migration and Invasion of Gastric Epithelial Cells

To investigate whether H. pylori lysate would regulate the migratory and invasive ability of GES-1 and MKN-45 cells, Cul30-GES-1, B-GES-1, Cul30-MKN-45, and B-MKN-45 cells were cultured with H. pylori lysate (2 μg/mL for GES-1 cells and 1.5 μg/mL for MKN-45 cells) or H. pylori (6×106 CFU/mL) for 24 h. The results of the wound healing assay showed that the migratory ability of Cul30-GES-1 exposed to H. pylori lysate or H. pylori was significantly inhibited compared with that of B-GES-1 cells ( ). The transwell migration assay yielded consistent results ( ). These data revealed that a 24-h exposure to H. pylori lysate had no significant effect on the migratory ability of GES-1 cells, but long-term exposure to H. pylori lysate could significantly inhibit GES-1 cell migration. Nevertheless, in MKN-45 cells, H. pylori lysate or H. pylori exposure only promoted the migratory ability of B-MKN-45 cells with no significant differences ( ), indicating that long-term exposure of H. pylori lysate did not inhibit migration of gastric cancer cells.
Figure 2

Sustained exposure to H. pylori lysate alters migration and invasion of GES-1 and MKN-45 cells. GES-1 or MKN-45 cells were treated with H. pylori lysate (2 μg/mL for GES-1 cells and 1.5 μg/mL for MKN-45 cells) or H. pylori (6×106 CFU/mL) for 24 h. (A) The wound healing assay was used to determine the migration of Cul30-GES-1 and B-GES-1 cells exposure to H. pylori lysate or H. pylori. Red lines represent the borders of the wounds (n=5 experiments). (B–E) Transwell migration (B, C) and Transwell invasion (D, E) assays were performed to detect the migration and invasion ability of Cul30-GES-1, B-GES-1, Cul30-MKN-45, and B-MKN-45 cells exposed to H. pylori lysate or H. pylori. (F–K) Expression of CCL-20 (F), CCL-28 (G), and CXCL-2 (H) in GES-1 cells, and the expression of CCL-20 (I), CCL-28 (J), and CXCL-2 (K) in MKN-45 cells were measured by Luminex assays. n = 3. *p < 0.05, **p < 0.01.

Sustained exposure to H. pylori lysate alters migration and invasion of GES-1 and MKN-45 cells. GES-1 or MKN-45 cells were treated with H. pylori lysate (2 μg/mL for GES-1 cells and 1.5 μg/mL for MKN-45 cells) or H. pylori (6×106 CFU/mL) for 24 h. (A) The wound healing assay was used to determine the migration of Cul30-GES-1 and B-GES-1 cells exposure to H. pylori lysate or H. pylori. Red lines represent the borders of the wounds (n=5 experiments). (B–E) Transwell migration (B, C) and Transwell invasion (D, E) assays were performed to detect the migration and invasion ability of Cul30-GES-1, B-GES-1, Cul30-MKN-45, and B-MKN-45 cells exposed to H. pylori lysate or H. pylori. (F–K) Expression of CCL-20 (F), CCL-28 (G), and CXCL-2 (H) in GES-1 cells, and the expression of CCL-20 (I), CCL-28 (J), and CXCL-2 (K) in MKN-45 cells were measured by Luminex assays. n = 3. *p < 0.05, **p < 0.01. For the cell invasion assay, short-term exposure to H. pylori lysate or H. pylori promoted the invasive ability of B-GES-1 cells, but it inhibited the invasion of Cul30-GES-1 cells ( ). In addition, the invasive ability of Cul30-MKN-45 cells challenged by the H. pylori lysate increased significantly ( ). These results indicated that exposure to H. pylori lysate promoted the invasion of gastric epithelial cells but inhibited the invasion of cells co-cultured with H. pylori lysate. However, treatment of H. pylori lysate did not affect the invasive ability of gastric adenocarcinoma cells, but instead promoted the invasion of MKN-45 cells co-cultured with H. pylori lysate.

Sustained Exposure to H. pylori Lysate Inhibited the Expression of CCL20, CCL28, and CXCL-2 of Gastric Epithelial Cells

The long-term exposure to H. pylori lysate inhibited the migration and invasion of normal gastric epithelial cells, but it had no effect on cancer cells. To investigate the mechanisms that altered migration and invasion of gastric cells, we evaluated the expression of cytokines CCL20, CCL28, and CXCL-2, which promote the migration and invasion of various cancer cells (24–26). Data showed that the expression of CCL20, CCL28, and CXCL-2 in Cul30-GES-1 cells under the treatment of H. pylori (6×106 CFU/mL) or lysate (2 μg/mL for GES-1 cells and 1.5 μg/mL for MKN-45 cells) for 24 h significantly decreased relative to B-GES-1 cells ( ). However, the expression levels of these cytokines in Cul30-MKN-45 cells increased significantly compared with those of B-MKN-45 cells (p<0.01, ). These results further confirmed that long-term exposure to H. pylori lysate altered migration and invasion of gastric epithelial cells.

Autophagy of Gastric Epithelial Cells Was Inhibited by Persistent Treatment With H. pylori Lysate

After treating Cul30-GES-1 and B-GES-1 cells with H. pylori lysate (2 μg/mL) or H. pylori (6×106 CFU/mL) for 24 h, the expression of an important indicator of autophagy LC3b-II (27) in B-GES-1 cells and Cul30-GES-1 cells treated with H. pylori lysate or H. pylori was upregulated in both cell lines. Further, the level of LC3b-II in H. pylori-treated B-GES-1 cells was significantly higher than that in cells exposed to lysate. Moreover, the expression of LC3b-II in Cul30-GES-1 cells co-cultured with H. pylori lysate or H. pylori was significantly lower than that in B-GES-1 cells ( ). These results demonstrated that long-term exposure of H. pylori lysate inhibited the autophagy of GES-1 cells. We then detected expression levels of vital autophagy regulator IFN-γ and FAS (28, 29) in B-GES-1 and Cul30-GES-1 cells under different conditions, and further confirmed the above results ( ).
Figure 3

The treatment of H. pylori lysate inhibits autophagy of GES-1 cells. Cul30-GES-1 and B-GES-1 cells were challenged with H. pylori lysate (2 μg/mL) or H. pylori (6×106 CFU/mL) for 24 h, and the expression of LC3b-II/LC3b-I (A) and p62 (D) in Cul30-GES-1 and B-GES-1 cells exposed to H. pylori lysate or H. pylori were detected by western blot. The expression of IFN-γ (B) and FAS (C) were measured by Luminex assays. (E) Representative fluorescence images of autophagosomes and autolysosomes in GES-1cells treated with H. pylori lysate using the tandem mCherry-EGFP-LC3 fusion protein assay. The autophagy flux was evaluated by the ratio of red spots to yellow spots. The yellow spots indicate autophagosomes, while the red spots indicate autolysosomes. If the phagosome and lysosome fuses normally, then the red fluorescence is greater than the yellow fluorescence. If downstream autophagy is blocked, the phagosome and lysosome cannot fuse normally, and then yellow fluorescence is the main color visualized. n=3. *p < 0.05, **p < 0.01.

The treatment of H. pylori lysate inhibits autophagy of GES-1 cells. Cul30-GES-1 and B-GES-1 cells were challenged with H. pylori lysate (2 μg/mL) or H. pylori (6×106 CFU/mL) for 24 h, and the expression of LC3b-II/LC3b-I (A) and p62 (D) in Cul30-GES-1 and B-GES-1 cells exposed to H. pylori lysate or H. pylori were detected by western blot. The expression of IFN-γ (B) and FAS (C) were measured by Luminex assays. (E) Representative fluorescence images of autophagosomes and autolysosomes in GES-1cells treated with H. pylori lysate using the tandem mCherry-EGFP-LC3 fusion protein assay. The autophagy flux was evaluated by the ratio of red spots to yellow spots. The yellow spots indicate autophagosomes, while the red spots indicate autolysosomes. If the phagosome and lysosome fuses normally, then the red fluorescence is greater than the yellow fluorescence. If downstream autophagy is blocked, the phagosome and lysosome cannot fuse normally, and then yellow fluorescence is the main color visualized. n=3. *p < 0.05, **p < 0.01. The expression of LC3b-II and SQSTM1/p62 is regulated by the production and removal of autophagosomes (27). We next evaluated the expression of p62 in lysate-treated GES-1 cells. Western blot assays showed that the p62 level was inhibited in B-GES-1 cells after 24-h treatment of H. pylori lysate, while it was enhanced in Cul30-GES-1 cells ( ). Furthermore, we transfected B-GES-1 and Cul30-GES-1 cells with mCherry-EGFP-LC3 lentiviral vector. The EGFP signal in the mCherry-EGFP-LC3 fusion protein was quenched under acidic pH in autophagolysosomes, which allowed easier detection of autophagolysosomes (GFP-negative/RFP-positive; red dots) and autophagosomes (GFP positive/RFP positive; yellow dots) ( ). In B-GES-1 and lysate-treated B-GES-1 cells, the red puncta were more numerous than the yellow puncta, which was in contrast with Cul30-GES-1 cells ( ). These observations suggested that long-term treatment of H. pylori lysate might inhibit autophagy flux of GES-1 cells.

Constant Treatment of H. pylori Lysate Inhibited Apoptosis of GES-1 Cells and Contributed to a Tendency for Cell Canceration

We next identified whether H. pylori lysate would regulate the apoptosis of GES-1 cells. After being challenged by H. pylori lysate (2 μg/mL) or H. pylori (6×106 CFU/mL) for 24 h, the expression of caspase-3 in Cul30-GES-1 cells decreased significantly, compared with that of B-GES-1 cells ( ). We also stained the nucleus of GES-1 cells with Hoechst and performed flow cytometry analysis, and the results further supported the above results ( ). In addition, we evaluated the expression of TNF-α, SLPI, and TFPI, which promote cell death (30–32). The expression levels of SLPI in Cul30-GES-1 cells treated with H. pylori or H. pylori lysate were significantly decreased compared to the control group ( ). After continuous co-culture with H. pylori lysate, the expression of TNF-α in Cul30-GES-1 cells showed a decreased trend ( ). However, there were no significant differences in the expression of TFPI between the two groups ( ).
Figure 4

Continuous treatment of H. pylori lysate inhibits apoptosis of GES-1. Cul30-GES-1 and B-GES-1 cells were challenged with H. pylori lysate (2 μg/mL) or H. pylori (6×106 CFU/mL) for 24 h and (A) the expression of cleaved Caspase-3 in Cul30-GES-1 and B-GES-1 cells exposed to H. pylori lysate or H. pylori were analyzed by Western blot. (B) Cells treated with H. pylori lysate or H. pylori stained with Hoechst 33342 (10 μg/mL) for 10 min. Nuclear morphologic changes were examined under a fluorescence microscope. (C) Cell apoptosis detected by flow cytometry. (D–F) The expression of SLPI (D), TNF-α (E), and TFPI (F) of B-GES-1 and Cul30-GES-1 cells were measured by Luminex assays. (G–I) Real-time qPCR results showing mRNA levels of SSH1 (G), CLC3 (H), and SIRT4 (I) of Cul30-GES-1, and normalized to control cells. n=3. *p < 0.05, **p < 0.01.

Continuous treatment of H. pylori lysate inhibits apoptosis of GES-1. Cul30-GES-1 and B-GES-1 cells were challenged with H. pylori lysate (2 μg/mL) or H. pylori (6×106 CFU/mL) for 24 h and (A) the expression of cleaved Caspase-3 in Cul30-GES-1 and B-GES-1 cells exposed to H. pylori lysate or H. pylori were analyzed by Western blot. (B) Cells treated with H. pylori lysate or H. pylori stained with Hoechst 33342 (10 μg/mL) for 10 min. Nuclear morphologic changes were examined under a fluorescence microscope. (C) Cell apoptosis detected by flow cytometry. (D–F) The expression of SLPI (D), TNF-α (E), and TFPI (F) of B-GES-1 and Cul30-GES-1 cells were measured by Luminex assays. (G–I) Real-time qPCR results showing mRNA levels of SSH1 (G), CLC3 (H), and SIRT4 (I) of Cul30-GES-1, and normalized to control cells. n=3. *p < 0.05, **p < 0.01. Given that persistent stimulation by H. pylori lysate exposure promoted proliferation and inhibited autophagy and apoptosis of GES-1 cells, we hypothesized that the treatment could promote the tendency for malignant progression. We detected the mRNA expression level of three gastric cancer biomarkers, chloride channel-3 (CLC-3), slingshot protein phosphatase 1 (SSH1), and sirtuin 4 (SIRT4) (33–35) in Cul30-GES-1 and B-GES-1 cells. We found that the mRNA levels of SSH1 and CLC3 increased significantly, while SIRT4 decreased, compared with the control group ( ). These data suggested that long-term stimulation by H. pylori lysate may contribute to the tendency of malignant transformation of gastric epithelial cells.

Screening of Genes Involved in H. pylori-Induced Gastric Cancer Based on TCGA Database

To determine potential pathways affected by persistence stimulation by H. pylori lysate, we downloaded a dataset from a patient cohort with gastric adenocarcinoma from the TCGA database (https://cancergenome.nih.gov/). We divided the data into two groups according to patients with (n=17) or without H. pylori infection (n=115). We found that compared with H. pylori negative group, H. pylori infection induced the downregulation of the forkhead box O4 (FOXO4) gene ( ), upregulation of B-cell lymphoma-2 (BCL2), and upregulation of growth arrest and DNA-damage-inducible Beta (GADD45B) genes ( ). Moreover, H. pylori infection resulted in upregulation of RIPK2, TNF receptor-associated factor (TRAF)1 and TRAF2 genes, and downregulation of autophagy related 12 homolog (ATG12) genes, although these differences were not statistically significant ( ).
Figure 5

Pathways related to the inhibition of autophagy and apoptosis of gastric epithelial cells sustained exposure to H. pylori lysate. (A–F) Gene expression among H. pylori-positive (n=17) and H. pylori-negative (n=115) patients with gastric adenocarcinoma analyzed from the TCGA database. Down-regulation of FOXO4 (A) and ATG12 (G) is shown in H. pylori-positive samples, while BCL2 (B), GADD45B (C), RIP2 (D), TRAF1 (E), and TRAF2 (F) are upregulated. (H) mRNA expression of related genes in B-GES-1 and Cul30-GES-1 cells tested by Real-time qPCR. (I–O) Expression of Nod1, RIP2, p-IKKA/IKKA, BCL-2, p-ERK/ERK, FOXO4, and BNIP3 measured by Western blot. n=3. *p < 0.05, **p < 0.01. NS, No Significance.

Pathways related to the inhibition of autophagy and apoptosis of gastric epithelial cells sustained exposure to H. pylori lysate. (A–F) Gene expression among H. pylori-positive (n=17) and H. pylori-negative (n=115) patients with gastric adenocarcinoma analyzed from the TCGA database. Down-regulation of FOXO4 (A) and ATG12 (G) is shown in H. pylori-positive samples, while BCL2 (B), GADD45B (C), RIP2 (D), TRAF1 (E), and TRAF2 (F) are upregulated. (H) mRNA expression of related genes in B-GES-1 and Cul30-GES-1 cells tested by Real-time qPCR. (I–O) Expression of Nod1, RIP2, p-IKKA/IKKA, BCL-2, p-ERK/ERK, FOXO4, and BNIP3 measured by Western blot. n=3. *p < 0.05, **p < 0.01. NS, No Significance.

The Nod Receptor Pathway Was Related to the Inhibition of Autophagy and Apoptosis of Gastric Epithelial Cells Under Persistent Treatment of H. pylori Lysate

Previous studies have indicated that Nod1-RIP2 regulates apoptosis through the NF-κB pathway and also regulates autophagy (36). Therefore, we evaluated the mRNA expression levels of Nod1, receptor-interacting protein 2 (RIP2), IκB kinase-α (IKBKA), and IκB kinase-β (IKBKB). All genes were significantly upregulated in Cul30-GES-1 cells, compared with B-GES-1 cells ( ). We then explored the mRNA levels of apoptosis-related downstream genes. B-cell lymphoma-XL (BCL-XL), BCL-2, GADD45B, TRAF1, TRAF2, and baculoviral IAP repeat-containing protein 2 (BIRC2) were upregulated in Cul30-GES-1 cells ( ). Moreover, we verified the protein levels of these genes. In accordance with the results above, the protein levels of Nod1, RIP2, IKKα, and BCL-2 increased significantly ( ). These results suggested that long-term exposure to H. pylori lysate may regulate the apoptosis of gastric epithelial cells through the Nod1-RIP2-NF-κB pathway. Nod1/RIP2 inhibits FOXO4 expression through the mitogen-activated protein kinase (MAPK)/ERK pathway (37). Thus, we verified the mRNA and protein levels of related pathway and vital genes. The results indicated that the mRNA level of TAK1 was significantly higher than that of the control group, while the mRNA level of FOXO4 was inhibited, although there were no statistically significant differences ( ). The mRNA levels of B-cell lymphoma-6 (BCL-6), BNIP3, and ATG12 were also downregulated ( ). Western blot showed that the phosphorylation level of extracellular regulated protein kinases (ERK) increased ( ), while the expression of FOXO4 and BNIP3 decreased significantly ( ). These results suggest that long-term exposure of H. pylori lysate may regulate apoptosis and autophagy of gastric epithelial cells through the Nod1-RIP2-MAPK/ERK-FOXO4 pathway.

Long-Term Infection of H. pylori Inhibited Autophagy and Apoptosis of Gastric Epithelial Cells In vivo

We presumed that H. pylori proliferates continuously in the course of chronic infection. H. pylori and its lysate are in constant contact with gastric epithelial cells in vivo. Autophagy and apoptosis of cells may be inhibited, which is conducive to the sustained colonization of H. pylori, and this may promote a tendency toward progression to gastric cancer. We then carried out in vivo experiments to verify the results of the above in vitro results. Mongolian gerbils were infected with the H. pylori 43504 strain for 90 weeks and then the gastric tissues were collected. The TUNEL staining assay and immunohistochemistry were performed to determine the degree of apoptosis and autophagy induced in gastric epithelial cells. Compared to the control group, the apoptosis and autophagy of gerbils continuously exposed to H. pylori infection were remarkably inhibited ( ). Bcl-2 and BNIP3 are two key regulators of autophagy and apoptosis (38). The expression of BNIP3 has also been reported to be absent in gastric cancer (39). The serum levels of Bcl-2 and BNIP3 in gerbils were also tested, and the results were consistent with the data above ( ). Furthermore, hyperplastic lesions were identified in the stomach tissue of gerbils infected with H. pylori ( ), showing a tendency of gastric lesions to transform to cancer.
Figure 6

Long-term infection of H. pylori inhibits autophagy and apoptosis of gastric epithelial cells in vivo. Mongolian gerbils were infected by H. pylori for 90 weeks. Serum and gastric tissue were collected. (A) TUNEL staining assay and immunohistochemistry (B) of LC3 was performed to determine the apoptosis and autophagy of gerbil gastric epithelial cells. (C) The serum levels of BCL-2 and BNIP3 in gerbils (tested by ELISA; n=5). *p < 0.05, **p < 0.01. (D–F) HE staining revealing the pathology of Mongolian gerbil stomach samples. Representative histologic images from H. pylori-infected gerbils at original magnification ×50 (D), ×100 (E), and ×200 (F).

Long-term infection of H. pylori inhibits autophagy and apoptosis of gastric epithelial cells in vivo. Mongolian gerbils were infected by H. pylori for 90 weeks. Serum and gastric tissue were collected. (A) TUNEL staining assay and immunohistochemistry (B) of LC3 was performed to determine the apoptosis and autophagy of gerbil gastric epithelial cells. (C) The serum levels of BCL-2 and BNIP3 in gerbils (tested by ELISA; n=5). *p < 0.05, **p < 0.01. (D–F) HE staining revealing the pathology of Mongolian gerbil stomach samples. Representative histologic images from H. pylori-infected gerbils at original magnification ×50 (D), ×100 (E), and ×200 (F).

Discussion

The global infection rate of H. pylori is about 44% (40). H. pylori is the most important risk factor for the development of gastric cancer (41). In the process of colonization, large amounts of H. pylori bacteria die and breakdown naturally, releasing lysate components, which influence the host cell in several ways. For example, its OMVs bind with pattern recognition receptors (PRR) on the surface of the host cell and regulate important cytological functions, including migration, invasion, apoptosis, autophagy, and carcinogenesis (22, 42, 43). However, there are some limitations that may have influenced the results of these studies. One is that the exposure time to bacterial lysate is generally too short to simulate an effective H. pylori infection in vivo. In addition, notably, when the components of the H. pylori lysate were isolated, they were antagonistic to each other in regulating some of the functions of the host cells. For instance, VacA induced apoptosis, while CagA blocked this effect and inhibited apoptosis. On the contrary, VacA also inhibited cytoskeleton deformity induced by CagA (27, 28). A single bacterial toxin cannot completely replace the regulatory effects of H. pylori on host cells. Therefore, it is necessary to use a H. pylori lysate instead of live bacteria to study the regulation of the host cell function by the continuous exposure to H. pylori infection. Considering that gastric epithelial cells are known to be initial contact points of bacteria in the gastric mucosa during H. pylori infection (44), human gastric epithelial cells GES-1 were used in our study. We co-cultured H. pylori lysate with GES-1 and MKN-45 cells for 30 generations and established a cell model of chronic stimulation of H. pylori lysate able to simulate the long-term symbiosis of H. pylori and host cells more closely, and to explore any relevant pathogenesis. Cell proliferation is related to apoptosis, autophagy, and carcinogenesis. However, the effects of H. pylori and H. pylori lysate on the proliferation of gastric epithelial cells are not consistent. In vitro experiments showed that H. pylori promoted proliferation of gastric epithelial cells at low concentrations but promoted apoptosis at higher concentrations (45). Nonetheless, the effects of H. pylori lysate were consistent with those of H. pylori (46). It is generally believed that the contrasting results are due to the various types of H. pylori strains used and the different gastric epithelial cells with which they interacted. In this study, we found that the lysate of the H. pylori ATCC 43504 strain inhibited proliferation of B-GES-1 and B-MKN-45 cells dose-dependently. To ensure the survival of cells and achieve the goal of long-term co-culture of cells and H. pylori lysate, we chose a concentration of H. pylori lysate when the cell value-added rate was about 70%–80% as the optimum concentration. After continuous co-culture with H. pylori lysate, proliferation of Cul30-GES-1 cells significantly increased, which may be due to the tolerance of cells to H. pylori lysate. Cell invasion and migration are two important characteristics in the process of cell carcinogenesis. H. pylori infection promotes migration and invasion of gastric epithelial cells in a CagA-dependent manner (47). CagA is translocated into the host cell mainly by the T4SS of H. pylori (48) and interacts with E-cadherin (49), resulting in the increase of movement and elongation of the host cell (50). In this study, differently from previous studies, we found that constant exposure to H. pylori lysate inhibited the migration and invasion of GES-1 cells. This may be due to the brief H. pylori stimulation, only 24 h, while we challenged gastric cells for 30 generations. Furthermore, ultrasonic lysis was used to prepare H. pylori lysate, and this process destroyed the T4SS, allowing only a small amount of CagA to enter the host cells through OMVs, and thus its promoting effect on cell migration and invasion may have been antagonized by other components, like lipopolysaccharide (LPS) (43). It is worth noting that differently from the effects on GES-1 cells, constant stimulation by H. pylori lysate showed less inhibition on the migration and invasion potential of MKN-45 cells, which may be due to the malignant properties of the cells. Although originating from normal cells, cancer cells have unique biological characteristics and behavior. For example, studies found that the mRNA and protein levels of HER2 in MKN-45 cells are significantly higher than that in GES-1 cells, and HER2 is subsequently proved to promote the migration and invasion of gastric cancer cells by upregulating CXCR4 (51). The higher migration and invasion characteristics of cancer cells may explain the reduced inhibitory effects of H. pylori lysate on the migration and invasion of MKN-45 cells. Autophagy disorders interfere with health and disease (52). Many studies have shown that the inflammatory pathway promotes tumor progression by regulating autophagy (53). When H. pylori infects gastric epithelial cells for a short time, VacA and urease induce autophagy (54), but after a prolonged co-culture, H. pylori destroys the autophagy pathway and accumulates cells due to dysfunctional autophagy (7). We found that sustained exposure to H. pylori lysate blocked the autophagy flux of Cul30-GES-1 cells, resulting in a failure of fusion of autophagosomes and autolysosomes, and the accumulation of cells with defective autophagy. H. pylori can invade gastric epithelial cells and are isolated by lysosomal acidified autophagy (55) to promote survival and colonization (56, 57). Our results suggest that H. pylori lysates play vital roles in the process of chronic infection and inhibit the autophagy of host cells, which contributes to the survival and colonization of H. pylori. The dysregulation of autophagy and apoptosis has adverse effects on the body and may even lead to cancer. It is believed that autophagy induced by H. pylori is associated with apoptosis, while autophagy occurs earlier than apoptosis (58). It has been reported that H. pylori infection inhibits apoptosis of the gastric epithelial cell (59, 60). We found that long-term stimulation of H. pylori lysate also inhibited the apoptosis of gastric epithelial cells, and we assumed that long-term exposure to H. pylori lysate may contribute to the initiation of the malignant transformation of the cell. To further evaluate the potential carcinogenic effects of exposure to H. pylori lysate, we detected mRNA levels of CLC-3, SSH1, and SIRT4, and the results confirmed our hypothesis. Sustained exposure to H. pylori lysate promoted the proliferation of gastric epithelial cells, inhibited autophagy and apoptosis, and facilitated the survival and colonization of bacteria, which may further promote the malignant transformation of cells. This was also confirmed by results in vivo. We infected Mongolian gerbils with H. pylori 43504 strain for 90 weeks. Although no carcinogenesis was evidenced in the stomach, dysplasia was present. Gastric epithelial dysplasia is a crucial pathology stage of the Correa cascade leading to gastric cancer (61). The observed dysplasia in model indicates that the pathological changes in the stomach of infected gerbils were indicative of transformation into cancer. These data suggest that H. pylori lysate acts as an “accomplice” in the process of H. pylori-induced gastric diseases. Subsequently, we explored the underlying pathways involved in the long-term exposure cell model. Through the screening of clinical data and cell experiments, we found that continuous stimulation of H. pylori lysate upregulated mRNA and protein levels of Nod1-RIP2-NF-κB and of downstream genes BCL-2 and GADD45B, which is consistent with previous reports. The NF-κB pathway regulates cell apoptosis (60) and the regulation of BCL-2 by NF-κB plays an important role in host cell apoptosis induced by H. pylori infection (62). H. pylori activates NF-κB, inflammation and gastric cancer via Nod1-dependent activation (63). Furthermore, Nod1 is a member of the Nod-like receptor (NLR) family, a cytoplasmic recognition receptor in cells, which recognizes a variety of ligands, including peptidoglycan (PGN) and flagellin from bacterial pathogens and viral and bacterial RNA (19). The Nod1 mRNA expression level was also shown to be upregulated in gastric cancer tissues (64). These results suggested that H. pylori lysate may regulate apoptosis of gastric epithelial cells via the Nod1-RIP2- NF-κB pathway. In addition, we found that long-term stimulation of H. pylori lysate promoted the phosphorylation of ERK, and then inhibited the levels of FOXO4 and its downstream genes, BCL-6, BNIP3, and ATG12, which is consistent with reports indicating that the FOXO pathway regulates cell autophagy and apoptosis (65, 66). In conclusion, we established a long-term gastric epithelial cell line model co-culture with H. pylori lysate to explore the effects of sustained exposure to H. pylori lysate on gastric cells, and we found that continuous treatment of H. pylori lysate promoted gastric epithelial cell proliferation and inhibited cell autophagy and apoptosis via the Nod1-NF-κB/MAPK-ERK/FOXO4 pathway ( ). In the process of H. pylori-induced gastric lesions, H. pylori lysate acts as an “accomplice.”
Figure 7

Schematic representation of the signaling pathways induced by prolonged exposure to H. pylori. Sustained exposure to H. pylori lysate inhibits apoptosis and autophagy of gastric epithelial cells via the Nod1-NF-κB/MAPK-ERK/FOXO4 pathway, which promotes cells survival, and may contribute to the tendency toward cell malignant transformation.

Schematic representation of the signaling pathways induced by prolonged exposure to H. pylori. Sustained exposure to H. pylori lysate inhibits apoptosis and autophagy of gastric epithelial cells via the Nod1-NF-κB/MAPK-ERK/FOXO4 pathway, which promotes cells survival, and may contribute to the tendency toward cell malignant transformation.

Data Availability Statement

Publicly available datasets were analyzed in this study. This data can be found here: https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga.

Ethics Statement

The animal study was reviewed and approved by the Animal Experiments and Experimental Animal Welfare Committee of CMU (Permit number: AEEI-2016-154), Capital Medical University.

Author Contributions

All authors contributed to the study conception and design. ZC and CL designed the study. YH and CW conducted the experiments. YH created the figures and wrote the manuscript. XZ conducted the animal experiments. XLu mainly provided technical and material support. JX cultivated H. pylori and prepared H. pylori lysate. JLv evaluated the gene expression via the TCGA database. MG, XH, XLi, JLu, and XD did analysis and interpretation of data. All authors contributed to the article and approved the submitted version.

Funding

This work was supported by the National Natural Science Foundation of China (No. 32070537, 31772545, 31970512, 31872308, 83902332), High-level Teachers in Beijing Municipal Universities in the Period of 13th Five Plan (No. IDHT20170516), National Key Research and Development Plan of China (No. 2017YFD0501602), and Beijing Science and Technology Program (D181100000518002).

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
  65 in total

1.  Helicobacter pylori outer inflammatory protein A (OipA) suppresses apoptosis of AGS gastric cells in vitro.

Authors:  Anis Rageh Al-Maleki; Mun Fai Loke; Sook Yin Lui; Nur Siti Khadijah Ramli; Yalda Khosravi; Chow Goon Ng; Gopinath Venkatraman; Khean-Lee Goh; Bow Ho; Jamuna Vadivelu
Journal:  Cell Microbiol       Date:  2017-08-25       Impact factor: 3.715

2.  A role for the bacterial outer membrane in the pathogenesis of Helicobacter pylori infection.

Authors:  J Keenan; T Day; S Neal; B Cook; G Perez-Perez; R Allardyce; P Bagshaw
Journal:  FEMS Microbiol Lett       Date:  2000-01-15       Impact factor: 2.742

3.  Catalase Enhances Viability of Human Chondrocytes in Culture by Reducing Reactive Oxygen Species and Counteracting Tumor Necrosis Factor-α-Induced Apoptosis.

Authors:  Siming Li; Xiaohong Yang; Zhencheng Feng; Pengzhen Wang; Weicong Zhu; Shuliang Cui
Journal:  Cell Physiol Biochem       Date:  2018-09-27

4.  FOXO3 Inhibits Human Gastric Adenocarcinoma (AGS) Cell Growth by Promoting Autophagy in an Acidic Microenvironment.

Authors:  Yuan Gao; Weiwei Qi; Libin Sun; Jing Lv; Wensheng Qiu; Shihai Liu
Journal:  Cell Physiol Biochem       Date:  2018-08-23

5.  Helicobacter pylori infection and the development of gastric cancer.

Authors:  N Uemura; S Okamoto; S Yamamoto; N Matsumura; S Yamaguchi; M Yamakido; K Taniyama; N Sasaki; R J Schlemper
Journal:  N Engl J Med       Date:  2001-09-13       Impact factor: 91.245

6.  The protein tyrosine phosphatase, Shp2, is required for the complete activation of the RAS/MAPK pathway by brain-derived neurotrophic factor.

Authors:  John B Easton; Amanda R Royer; David S Middlemas
Journal:  J Neurochem       Date:  2006-03-29       Impact factor: 5.372

Review 7.  Autophagy intersections with conventional and unconventional secretion in tissue development, remodeling and inflammation.

Authors:  Vojo Deretic; Shanya Jiang; Nicolas Dupont
Journal:  Trends Cell Biol       Date:  2012-06-05       Impact factor: 20.808

8.  Gastric epithelial cell death caused by Helicobacter suis and Helicobacter pylori γ-glutamyl transpeptidase is mainly glutathione degradation-dependent.

Authors:  Bram Flahou; Freddy Haesebrouck; Koen Chiers; Kim Van Deun; Lina De Smet; Bart Devreese; Isabel Vandenberghe; Herman Favoreel; Annemieke Smet; Frank Pasmans; Katharina D'Herde; Richard Ducatelle
Journal:  Cell Microbiol       Date:  2011-09-22       Impact factor: 3.715

9.  Helicobacter pylori induces MAPK phosphorylation and AP-1 activation via a NOD1-dependent mechanism.

Authors:  Cody C Allison; Thomas A Kufer; Elisabeth Kremmer; Maria Kaparakis; Richard L Ferrero
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

10.  Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).

Authors:  Daniel J Klionsky; Kotb Abdelmohsen; Akihisa Abe; Md Joynal Abedin; Hagai Abeliovich; Abraham Acevedo Arozena; Hiroaki Adachi; Christopher M Adams; Peter D Adams; Khosrow Adeli; Peter J Adhihetty; Sharon G Adler; Galila Agam; Rajesh Agarwal; Manish K Aghi; Maria Agnello; Patrizia Agostinis; Patricia V Aguilar; Julio Aguirre-Ghiso; Edoardo M Airoldi; Slimane Ait-Si-Ali; Takahiko Akematsu; Emmanuel T Akporiaye; Mohamed Al-Rubeai; Guillermo M Albaiceta; Chris Albanese; Diego Albani; Matthew L Albert; Jesus Aldudo; Hana Algül; Mehrdad Alirezaei; Iraide Alloza; Alexandru Almasan; Maylin Almonte-Beceril; Emad S Alnemri; Covadonga Alonso; Nihal Altan-Bonnet; Dario C Altieri; Silvia Alvarez; Lydia Alvarez-Erviti; Sandro Alves; Giuseppina Amadoro; Atsuo Amano; Consuelo Amantini; Santiago Ambrosio; Ivano Amelio; Amal O Amer; Mohamed Amessou; Angelika Amon; Zhenyi An; Frank A Anania; Stig U Andersen; Usha P Andley; Catherine K Andreadi; Nathalie Andrieu-Abadie; Alberto Anel; David K Ann; Shailendra Anoopkumar-Dukie; Manuela Antonioli; Hiroshi Aoki; Nadezda Apostolova; Saveria Aquila; Katia Aquilano; Koichi Araki; Eli Arama; Agustin Aranda; Jun Araya; Alexandre Arcaro; Esperanza Arias; Hirokazu Arimoto; Aileen R Ariosa; Jane L Armstrong; Thierry Arnould; Ivica Arsov; Katsuhiko Asanuma; Valerie Askanas; Eric Asselin; Ryuichiro Atarashi; Sally S Atherton; Julie D Atkin; Laura D Attardi; Patrick Auberger; Georg Auburger; Laure Aurelian; Riccardo Autelli; Laura Avagliano; Maria Laura Avantaggiati; Limor Avrahami; Suresh Awale; Neelam Azad; Tiziana Bachetti; Jonathan M Backer; Dong-Hun Bae; Jae-Sung Bae; Ok-Nam Bae; Soo Han Bae; Eric H Baehrecke; Seung-Hoon Baek; Stephen Baghdiguian; Agnieszka Bagniewska-Zadworna; Hua Bai; Jie Bai; Xue-Yuan Bai; Yannick Bailly; Kithiganahalli Narayanaswamy Balaji; Walter Balduini; Andrea Ballabio; Rena Balzan; Rajkumar Banerjee; Gábor Bánhegyi; Haijun Bao; Benoit Barbeau; Maria D Barrachina; Esther Barreiro; Bonnie Bartel; Alberto Bartolomé; Diane C Bassham; Maria Teresa Bassi; Robert C Bast; Alakananda Basu; Maria Teresa Batista; Henri Batoko; Maurizio Battino; Kyle Bauckman; Bradley L Baumgarner; K Ulrich Bayer; Rupert Beale; Jean-François Beaulieu; George R Beck; Christoph Becker; J David Beckham; Pierre-André Bédard; Patrick J Bednarski; Thomas J Begley; Christian Behl; Christian Behrends; Georg Mn Behrens; Kevin E Behrns; Eloy Bejarano; Amine Belaid; Francesca Belleudi; Giovanni Bénard; Guy Berchem; Daniele Bergamaschi; Matteo Bergami; Ben Berkhout; Laura Berliocchi; Amélie Bernard; Monique Bernard; Francesca Bernassola; Anne Bertolotti; Amanda S Bess; Sébastien Besteiro; Saverio Bettuzzi; Savita Bhalla; Shalmoli Bhattacharyya; Sujit K Bhutia; Caroline Biagosch; Michele Wolfe Bianchi; Martine Biard-Piechaczyk; Viktor Billes; Claudia Bincoletto; Baris Bingol; Sara W Bird; Marc Bitoun; Ivana Bjedov; Craig Blackstone; Lionel Blanc; Guillermo A Blanco; Heidi Kiil Blomhoff; Emilio Boada-Romero; Stefan Böckler; Marianne Boes; Kathleen Boesze-Battaglia; Lawrence H Boise; Alessandra Bolino; Andrea Boman; Paolo Bonaldo; Matteo Bordi; Jürgen Bosch; Luis M Botana; Joelle Botti; German Bou; Marina Bouché; Marion Bouchecareilh; Marie-Josée Boucher; Michael E Boulton; Sebastien G Bouret; Patricia Boya; Michaël Boyer-Guittaut; Peter V Bozhkov; Nathan Brady; Vania Mm Braga; Claudio Brancolini; Gerhard H Braus; José M Bravo-San Pedro; Lisa A Brennan; Emery H Bresnick; Patrick Brest; Dave Bridges; Marie-Agnès Bringer; Marisa Brini; Glauber C Brito; Bertha Brodin; Paul S Brookes; Eric J Brown; Karen Brown; Hal E Broxmeyer; Alain Bruhat; Patricia Chakur Brum; John H Brumell; Nicola Brunetti-Pierri; Robert J Bryson-Richardson; Shilpa Buch; Alastair M Buchan; Hikmet Budak; Dmitry V Bulavin; Scott J Bultman; Geert Bultynck; Vladimir Bumbasirevic; Yan Burelle; Robert E Burke; Margit Burmeister; Peter Bütikofer; Laura Caberlotto; Ken Cadwell; Monika Cahova; Dongsheng Cai; Jingjing Cai; Qian Cai; Sara Calatayud; Nadine Camougrand; Michelangelo Campanella; Grant R Campbell; Matthew Campbell; Silvia Campello; Robin Candau; Isabella Caniggia; Lavinia Cantoni; Lizhi Cao; Allan B Caplan; Michele Caraglia; Claudio Cardinali; Sandra Morais Cardoso; Jennifer S Carew; Laura A Carleton; Cathleen R Carlin; Silvia Carloni; Sven R Carlsson; Didac Carmona-Gutierrez; Leticia Am Carneiro; Oliana Carnevali; Serena Carra; Alice Carrier; Bernadette Carroll; Caty Casas; Josefina Casas; Giuliana Cassinelli; Perrine Castets; Susana Castro-Obregon; Gabriella Cavallini; Isabella Ceccherini; Francesco Cecconi; Arthur I Cederbaum; Valentín Ceña; Simone Cenci; Claudia Cerella; Davide Cervia; Silvia Cetrullo; Hassan Chaachouay; Han-Jung Chae; Andrei S Chagin; Chee-Yin Chai; Gopal Chakrabarti; Georgios Chamilos; Edmond Yw Chan; Matthew Tv Chan; Dhyan Chandra; Pallavi Chandra; Chih-Peng Chang; Raymond Chuen-Chung Chang; Ta Yuan Chang; John C Chatham; Saurabh Chatterjee; Santosh Chauhan; Yongsheng Che; Michael E Cheetham; Rajkumar Cheluvappa; Chun-Jung Chen; Gang Chen; Guang-Chao Chen; Guoqiang Chen; Hongzhuan Chen; Jeff W Chen; Jian-Kang Chen; Min Chen; Mingzhou Chen; Peiwen Chen; Qi Chen; Quan Chen; Shang-Der Chen; Si Chen; Steve S-L Chen; Wei Chen; Wei-Jung Chen; Wen Qiang Chen; Wenli Chen; Xiangmei Chen; Yau-Hung Chen; Ye-Guang Chen; Yin Chen; Yingyu Chen; Yongshun Chen; Yu-Jen Chen; Yue-Qin Chen; Yujie Chen; Zhen Chen; Zhong Chen; Alan Cheng; Christopher Hk Cheng; Hua Cheng; Heesun Cheong; Sara Cherry; Jason Chesney; Chun Hei Antonio Cheung; Eric Chevet; Hsiang Cheng Chi; Sung-Gil Chi; Fulvio Chiacchiera; Hui-Ling Chiang; Roberto Chiarelli; Mario Chiariello; Marcello Chieppa; Lih-Shen Chin; Mario Chiong; Gigi Nc Chiu; Dong-Hyung Cho; Ssang-Goo Cho; William C Cho; Yong-Yeon Cho; Young-Seok Cho; Augustine Mk Choi; Eui-Ju Choi; Eun-Kyoung Choi; Jayoung Choi; Mary E Choi; Seung-Il Choi; Tsui-Fen Chou; Salem Chouaib; Divaker Choubey; Vinay Choubey; Kuan-Chih Chow; Kamal Chowdhury; Charleen T Chu; Tsung-Hsien Chuang; Taehoon Chun; Hyewon Chung; Taijoon Chung; Yuen-Li Chung; Yong-Joon Chwae; Valentina Cianfanelli; Roberto Ciarcia; Iwona A Ciechomska; Maria Rosa Ciriolo; Mara Cirone; Sofie Claerhout; Michael J Clague; Joan Clària; Peter Gh Clarke; Robert Clarke; Emilio Clementi; Cédric Cleyrat; Miriam Cnop; Eliana M Coccia; Tiziana Cocco; Patrice Codogno; Jörn Coers; Ezra Ew Cohen; David Colecchia; Luisa Coletto; Núria S Coll; Emma Colucci-Guyon; Sergio Comincini; Maria Condello; Katherine L Cook; Graham H Coombs; Cynthia D Cooper; J Mark Cooper; Isabelle Coppens; Maria Tiziana Corasaniti; Marco Corazzari; Ramon Corbalan; Elisabeth Corcelle-Termeau; Mario D Cordero; Cristina Corral-Ramos; Olga Corti; Andrea Cossarizza; Paola Costelli; Safia Costes; Susan L Cotman; Ana Coto-Montes; Sandra Cottet; Eduardo Couve; Lori R Covey; L Ashley Cowart; Jeffery S Cox; Fraser P Coxon; Carolyn B Coyne; Mark S Cragg; Rolf J Craven; Tiziana Crepaldi; Jose L Crespo; Alfredo Criollo; Valeria Crippa; Maria Teresa Cruz; Ana Maria Cuervo; Jose M Cuezva; Taixing Cui; Pedro R Cutillas; Mark J Czaja; Maria F Czyzyk-Krzeska; Ruben K Dagda; Uta Dahmen; Chunsun Dai; Wenjie Dai; Yun Dai; Kevin N Dalby; Luisa Dalla Valle; Guillaume Dalmasso; Marcello D'Amelio; Markus Damme; Arlette Darfeuille-Michaud; Catherine Dargemont; Victor M Darley-Usmar; Srinivasan Dasarathy; Biplab Dasgupta; Srikanta Dash; Crispin R Dass; Hazel Marie Davey; Lester M Davids; David Dávila; Roger J Davis; Ted M Dawson; Valina L Dawson; Paula Daza; Jackie de Belleroche; Paul de Figueiredo; Regina Celia Bressan Queiroz de Figueiredo; José de la Fuente; Luisa De Martino; Antonella De Matteis; Guido Ry De Meyer; Angelo De Milito; Mauro De Santi; Wanderley de Souza; Vincenzo De Tata; Daniela De Zio; Jayanta Debnath; Reinhard Dechant; Jean-Paul Decuypere; Shane Deegan; Benjamin Dehay; Barbara Del Bello; Dominic P Del Re; Régis Delage-Mourroux; Lea Md Delbridge; Louise Deldicque; Elizabeth Delorme-Axford; Yizhen Deng; Joern Dengjel; Melanie Denizot; Paul Dent; Channing J Der; Vojo Deretic; Benoît Derrien; Eric Deutsch; Timothy P Devarenne; Rodney J Devenish; Sabrina Di Bartolomeo; Nicola Di Daniele; Fabio Di Domenico; Alessia Di Nardo; Simone Di Paola; Antonio Di Pietro; Livia Di Renzo; Aaron DiAntonio; Guillermo Díaz-Araya; Ines Díaz-Laviada; Maria T Diaz-Meco; Javier Diaz-Nido; Chad A Dickey; Robert C Dickson; Marc Diederich; Paul Digard; Ivan Dikic; Savithrama P Dinesh-Kumar; Chan Ding; Wen-Xing Ding; Zufeng Ding; Luciana Dini; Jörg Hw Distler; Abhinav Diwan; Mojgan Djavaheri-Mergny; Kostyantyn Dmytruk; Renwick Cj Dobson; Volker Doetsch; Karol Dokladny; Svetlana Dokudovskaya; Massimo Donadelli; X Charlie Dong; Xiaonan Dong; Zheng Dong; Terrence M Donohue; Kelly S Doran; Gabriella D'Orazi; Gerald W Dorn; Victor Dosenko; Sami Dridi; Liat Drucker; Jie Du; Li-Lin Du; Lihuan Du; André du Toit; Priyamvada Dua; Lei Duan; Pu Duann; Vikash Kumar Dubey; Michael R Duchen; Michel A Duchosal; Helene Duez; Isabelle Dugail; Verónica I Dumit; Mara C Duncan; Elaine A Dunlop; William A Dunn; Nicolas Dupont; Luc Dupuis; Raúl V Durán; Thomas M Durcan; Stéphane Duvezin-Caubet; Umamaheswar Duvvuri; Vinay Eapen; Darius Ebrahimi-Fakhari; Arnaud Echard; Leopold Eckhart; Charles L Edelstein; Aimee L Edinger; Ludwig Eichinger; Tobias Eisenberg; Avital Eisenberg-Lerner; N Tony Eissa; Wafik S El-Deiry; Victoria El-Khoury; Zvulun Elazar; Hagit Eldar-Finkelman; Chris Jh Elliott; Enzo Emanuele; Urban Emmenegger; Nikolai Engedal; Anna-Mart Engelbrecht; Simone Engelender; Jorrit M Enserink; Ralf Erdmann; Jekaterina Erenpreisa; Rajaraman Eri; Jason L Eriksen; Andreja Erman; Ricardo Escalante; Eeva-Liisa Eskelinen; Lucile Espert; Lorena Esteban-Martínez; Thomas J Evans; Mario Fabri; Gemma Fabrias; Cinzia Fabrizi; Antonio Facchiano; Nils J Færgeman; Alberto Faggioni; W Douglas Fairlie; Chunhai Fan; Daping Fan; Jie Fan; Shengyun Fang; Manolis Fanto; Alessandro Fanzani; Thomas Farkas; Mathias Faure; Francois B Favier; Howard Fearnhead; Massimo Federici; Erkang Fei; Tania C Felizardo; Hua Feng; Yibin Feng; Yuchen Feng; Thomas A Ferguson; Álvaro F Fernández; Maite G Fernandez-Barrena; Jose C Fernandez-Checa; Arsenio Fernández-López; Martin E Fernandez-Zapico; Olivier Feron; Elisabetta Ferraro; Carmen Veríssima Ferreira-Halder; Laszlo Fesus; Ralph Feuer; Fabienne C Fiesel; Eduardo C Filippi-Chiela; Giuseppe Filomeni; Gian Maria Fimia; John H Fingert; Steven Finkbeiner; Toren Finkel; Filomena Fiorito; Paul B Fisher; Marc Flajolet; Flavio Flamigni; Oliver Florey; Salvatore Florio; R Andres Floto; Marco Folini; Carlo Follo; Edward A Fon; Francesco Fornai; Franco Fortunato; Alessandro Fraldi; Rodrigo Franco; Arnaud Francois; Aurélie François; Lisa B Frankel; Iain Dc Fraser; Norbert Frey; Damien G Freyssenet; Christian Frezza; Scott L Friedman; Daniel E Frigo; Dongxu Fu; José M Fuentes; Juan Fueyo; Yoshio Fujitani; Yuuki Fujiwara; Mikihiro Fujiya; Mitsunori Fukuda; Simone Fulda; Carmela Fusco; Bozena Gabryel; Matthias Gaestel; Philippe Gailly; Malgorzata Gajewska; Sehamuddin Galadari; Gad Galili; Inmaculada Galindo; Maria F Galindo; Giovanna Galliciotti; Lorenzo Galluzzi; Luca Galluzzi; Vincent Galy; Noor Gammoh; Sam Gandy; Anand K Ganesan; Swamynathan Ganesan; Ian G Ganley; Monique Gannagé; Fen-Biao Gao; Feng Gao; Jian-Xin Gao; Lorena García Nannig; Eleonora García Véscovi; Marina Garcia-Macía; Carmen Garcia-Ruiz; Abhishek D Garg; Pramod Kumar Garg; Ricardo Gargini; Nils Christian Gassen; Damián Gatica; Evelina Gatti; Julie Gavard; Evripidis Gavathiotis; Liang Ge; Pengfei Ge; Shengfang Ge; Po-Wu Gean; Vania Gelmetti; Armando A Genazzani; Jiefei Geng; Pascal Genschik; Lisa Gerner; Jason E Gestwicki; David A Gewirtz; Saeid Ghavami; Eric Ghigo; Debabrata Ghosh; Anna Maria Giammarioli; Francesca Giampieri; Claudia Giampietri; Alexandra Giatromanolaki; Derrick J Gibbings; Lara Gibellini; Spencer B Gibson; Vanessa Ginet; Antonio Giordano; Flaviano Giorgini; Elisa Giovannetti; Stephen E Girardin; Suzana Gispert; Sandy Giuliano; Candece L Gladson; Alvaro Glavic; Martin Gleave; Nelly Godefroy; Robert M Gogal; Kuppan Gokulan; Gustavo H Goldman; Delia Goletti; Michael S Goligorsky; Aldrin V Gomes; Ligia C Gomes; Hernando Gomez; Candelaria Gomez-Manzano; Rubén Gómez-Sánchez; Dawit Ap Gonçalves; Ebru Goncu; Qingqiu Gong; Céline Gongora; Carlos B Gonzalez; Pedro Gonzalez-Alegre; Pilar Gonzalez-Cabo; Rosa Ana González-Polo; Ing Swie Goping; Carlos Gorbea; Nikolai V Gorbunov; Daphne R Goring; Adrienne M Gorman; Sharon M Gorski; Sandro Goruppi; Shino Goto-Yamada; Cecilia Gotor; Roberta A Gottlieb; Illana Gozes; Devrim Gozuacik; Yacine Graba; Martin Graef; Giovanna E Granato; Gary Dean Grant; Steven Grant; Giovanni Luca Gravina; Douglas R Green; Alexander Greenhough; Michael T Greenwood; Benedetto Grimaldi; Frédéric Gros; Charles Grose; Jean-Francois Groulx; Florian Gruber; Paolo Grumati; Tilman Grune; Jun-Lin Guan; Kun-Liang Guan; Barbara Guerra; Carlos Guillen; Kailash Gulshan; Jan Gunst; Chuanyong Guo; Lei Guo; Ming Guo; Wenjie Guo; Xu-Guang Guo; Andrea A Gust; Åsa B Gustafsson; Elaine Gutierrez; Maximiliano G Gutierrez; Ho-Shin Gwak; Albert Haas; James E Haber; Shinji Hadano; Monica Hagedorn; David R Hahn; Andrew J Halayko; Anne Hamacher-Brady; Kozo Hamada; Ahmed Hamai; Andrea Hamann; Maho Hamasaki; Isabelle Hamer; Qutayba Hamid; Ester M Hammond; Feng Han; Weidong Han; James T Handa; John A Hanover; Malene Hansen; Masaru Harada; Ljubica Harhaji-Trajkovic; J Wade Harper; Abdel Halim Harrath; Adrian L Harris; James Harris; Udo Hasler; Peter Hasselblatt; Kazuhisa Hasui; Robert G Hawley; Teresa S Hawley; Congcong He; Cynthia Y He; Fengtian He; Gu He; Rong-Rong He; Xian-Hui He; You-Wen He; Yu-Ying He; Joan K Heath; Marie-Josée Hébert; Robert A Heinzen; Gudmundur Vignir Helgason; Michael Hensel; Elizabeth P Henske; Chengtao Her; Paul K Herman; Agustín Hernández; Carlos Hernandez; Sonia Hernández-Tiedra; Claudio Hetz; P Robin Hiesinger; Katsumi Higaki; Sabine Hilfiker; Bradford G Hill; Joseph A Hill; William D Hill; Keisuke Hino; Daniel Hofius; Paul Hofman; Günter U Höglinger; Jörg Höhfeld; Marina K Holz; Yonggeun Hong; David A Hood; Jeroen Jm Hoozemans; Thorsten Hoppe; Chin Hsu; Chin-Yuan Hsu; Li-Chung Hsu; Dong Hu; Guochang Hu; Hong-Ming Hu; Hongbo Hu; Ming Chang Hu; Yu-Chen Hu; Zhuo-Wei Hu; Fang Hua; Ya Hua; Canhua Huang; Huey-Lan Huang; Kuo-How Huang; Kuo-Yang Huang; Shile Huang; Shiqian Huang; Wei-Pang Huang; Yi-Ran Huang; Yong Huang; Yunfei Huang; Tobias B Huber; Patricia Huebbe; Won-Ki Huh; Juha J Hulmi; Gang Min Hur; James H Hurley; Zvenyslava Husak; Sabah Na Hussain; Salik Hussain; Jung Jin Hwang; Seungmin Hwang; Thomas Is Hwang; Atsuhiro Ichihara; Yuzuru Imai; Carol Imbriano; Megumi Inomata; Takeshi Into; Valentina Iovane; Juan L Iovanna; Renato V Iozzo; Nancy Y Ip; Javier E Irazoqui; Pablo Iribarren; Yoshitaka Isaka; Aleksandra J Isakovic; Harry Ischiropoulos; Jeffrey S Isenberg; Mohammad Ishaq; Hiroyuki Ishida; Isao Ishii; Jane E Ishmael; Ciro Isidoro; Ken-Ichi Isobe; Erika Isono; Shohreh Issazadeh-Navikas; Koji Itahana; Eisuke Itakura; Andrei I Ivanov; Anand Krishnan V Iyer; José M Izquierdo; Yotaro Izumi; Valentina Izzo; Marja Jäättelä; Nadia Jaber; Daniel John Jackson; William T Jackson; Tony George Jacob; Thomas S Jacques; Chinnaswamy Jagannath; Ashish Jain; Nihar Ranjan Jana; Byoung Kuk Jang; Alkesh Jani; Bassam Janji; Paulo Roberto Jannig; Patric J Jansson; Steve Jean; Marina Jendrach; Ju-Hong Jeon; Niels Jessen; Eui-Bae Jeung; Kailiang Jia; Lijun Jia; Hong Jiang; Hongchi Jiang; Liwen Jiang; Teng Jiang; Xiaoyan Jiang; Xuejun Jiang; Xuejun Jiang; Ying Jiang; Yongjun Jiang; Alberto Jiménez; Cheng Jin; Hongchuan Jin; Lei Jin; Meiyan Jin; Shengkan Jin; Umesh Kumar Jinwal; Eun-Kyeong Jo; Terje Johansen; Daniel E Johnson; Gail Vw Johnson; James D Johnson; Eric Jonasch; Chris Jones; Leo Ab Joosten; Joaquin Jordan; Anna-Maria Joseph; Bertrand Joseph; Annie M Joubert; Dianwen Ju; Jingfang Ju; Hsueh-Fen Juan; Katrin Juenemann; Gábor Juhász; Hye Seung Jung; Jae U Jung; Yong-Keun Jung; Heinz Jungbluth; Matthew J Justice; Barry Jutten; Nadeem O Kaakoush; Kai Kaarniranta; Allen Kaasik; Tomohiro Kabuta; Bertrand Kaeffer; Katarina Kågedal; Alon Kahana; Shingo Kajimura; Or Kakhlon; Manjula Kalia; Dhan V Kalvakolanu; Yoshiaki Kamada; Konstantinos Kambas; Vitaliy O Kaminskyy; Harm H Kampinga; Mustapha Kandouz; Chanhee Kang; Rui Kang; Tae-Cheon Kang; Tomotake Kanki; Thirumala-Devi Kanneganti; Haruo Kanno; Anumantha G Kanthasamy; Marc Kantorow; Maria Kaparakis-Liaskos; Orsolya Kapuy; Vassiliki Karantza; Md Razaul Karim; Parimal Karmakar; Arthur Kaser; Susmita Kaushik; Thomas Kawula; A Murat Kaynar; Po-Yuan Ke; Zun-Ji Ke; John H Kehrl; Kate E Keller; Jongsook Kim Kemper; Anne K Kenworthy; Oliver Kepp; Andreas Kern; Santosh Kesari; David Kessel; Robin Ketteler; Isis do Carmo Kettelhut; Bilon Khambu; Muzamil Majid Khan; Vinoth Km Khandelwal; Sangeeta Khare; Juliann G Kiang; Amy A Kiger; Akio Kihara; Arianna L Kim; Cheol Hyeon Kim; Deok Ryong Kim; Do-Hyung Kim; Eung Kweon Kim; Hye Young Kim; Hyung-Ryong Kim; Jae-Sung Kim; Jeong Hun Kim; Jin Cheon Kim; Jin Hyoung Kim; Kwang Woon Kim; Michael D Kim; Moon-Moo Kim; Peter K Kim; Seong Who Kim; Soo-Youl Kim; Yong-Sun Kim; Yonghyun Kim; Adi Kimchi; Alec C Kimmelman; Tomonori Kimura; Jason S King; Karla Kirkegaard; Vladimir Kirkin; Lorrie A Kirshenbaum; Shuji Kishi; Yasuo Kitajima; Katsuhiko Kitamoto; Yasushi Kitaoka; Kaio Kitazato; Rudolf A Kley; Walter T Klimecki; Michael Klinkenberg; Jochen Klucken; Helene Knævelsrud; Erwin Knecht; Laura Knuppertz; Jiunn-Liang Ko; Satoru Kobayashi; Jan C Koch; Christelle Koechlin-Ramonatxo; Ulrich Koenig; Young Ho Koh; Katja Köhler; Sepp D Kohlwein; Masato Koike; Masaaki Komatsu; Eiki Kominami; Dexin Kong; Hee Jeong Kong; Eumorphia G Konstantakou; Benjamin T Kopp; Tamas Korcsmaros; Laura Korhonen; Viktor I Korolchuk; Nadya V Koshkina; Yanjun Kou; Michael I Koukourakis; Constantinos Koumenis; Attila L Kovács; Tibor Kovács; Werner J Kovacs; Daisuke Koya; Claudine Kraft; Dimitri Krainc; Helmut Kramer; Tamara Kravic-Stevovic; Wilhelm Krek; Carole Kretz-Remy; Roswitha Krick; Malathi Krishnamurthy; Janos Kriston-Vizi; Guido Kroemer; Michael C Kruer; Rejko Kruger; Nicholas T Ktistakis; Kazuyuki Kuchitsu; Christian Kuhn; Addanki Pratap Kumar; Anuj Kumar; Ashok Kumar; Deepak Kumar; Dhiraj Kumar; Rakesh Kumar; Sharad Kumar; Mondira Kundu; Hsing-Jien Kung; Atsushi Kuno; Sheng-Han Kuo; Jeff Kuret; Tino Kurz; Terry Kwok; Taeg Kyu Kwon; Yong Tae Kwon; Irene Kyrmizi; Albert R La Spada; Frank Lafont; Tim Lahm; Aparna Lakkaraju; Truong Lam; Trond Lamark; Steve Lancel; Terry H Landowski; Darius J R Lane; Jon D Lane; Cinzia Lanzi; Pierre Lapaquette; Louis R Lapierre; Jocelyn Laporte; Johanna Laukkarinen; Gordon W Laurie; Sergio Lavandero; Lena Lavie; Matthew J LaVoie; Betty Yuen Kwan Law; Helen Ka-Wai Law; Kelsey B Law; Robert Layfield; Pedro A Lazo; Laurent Le Cam; Karine G Le Roch; Hervé Le Stunff; Vijittra Leardkamolkarn; Marc Lecuit; Byung-Hoon Lee; Che-Hsin Lee; Erinna F Lee; Gyun Min Lee; He-Jin Lee; Hsinyu Lee; Jae Keun Lee; Jongdae Lee; Ju-Hyun Lee; Jun Hee Lee; Michael Lee; Myung-Shik Lee; Patty J Lee; Sam W Lee; Seung-Jae Lee; Shiow-Ju Lee; Stella Y Lee; Sug Hyung Lee; Sung Sik Lee; Sung-Joon Lee; Sunhee Lee; Ying-Ray Lee; Yong J Lee; Young H Lee; Christiaan Leeuwenburgh; Sylvain Lefort; Renaud Legouis; Jinzhi Lei; Qun-Ying Lei; David A Leib; Gil Leibowitz; Istvan Lekli; Stéphane D Lemaire; John J Lemasters; Marius K Lemberg; Antoinette Lemoine; Shuilong Leng; Guido Lenz; Paola Lenzi; Lilach O Lerman; Daniele Lettieri Barbato; Julia I-Ju Leu; Hing Y Leung; Beth Levine; Patrick A Lewis; Frank Lezoualc'h; Chi Li; Faqiang Li; Feng-Jun Li; Jun Li; Ke Li; Lian Li; Min Li; Min Li; Qiang Li; Rui Li; Sheng Li; Wei Li; Wei Li; Xiaotao Li; Yumin Li; Jiqin Lian; Chengyu Liang; Qiangrong Liang; Yulin Liao; Joana Liberal; Pawel P Liberski; Pearl Lie; Andrew P Lieberman; Hyunjung Jade Lim; Kah-Leong Lim; Kyu Lim; Raquel T Lima; Chang-Shen Lin; Chiou-Feng Lin; Fang Lin; Fangming Lin; Fu-Cheng Lin; Kui Lin; Kwang-Huei Lin; Pei-Hui Lin; Tianwei Lin; Wan-Wan Lin; Yee-Shin Lin; Yong Lin; Rafael Linden; Dan Lindholm; Lisa M Lindqvist; Paul Lingor; Andreas Linkermann; Lance A Liotta; Marta M Lipinski; Vitor A Lira; Michael P Lisanti; Paloma B Liton; Bo Liu; Chong Liu; Chun-Feng Liu; Fei Liu; Hung-Jen Liu; Jianxun Liu; Jing-Jing Liu; Jing-Lan Liu; Ke Liu; Leyuan Liu; Liang Liu; Quentin Liu; Rong-Yu Liu; Shiming Liu; Shuwen Liu; Wei Liu; Xian-De Liu; Xiangguo Liu; Xiao-Hong Liu; Xinfeng Liu; Xu Liu; Xueqin Liu; Yang Liu; Yule Liu; Zexian Liu; Zhe Liu; Juan P Liuzzi; Gérard Lizard; Mila Ljujic; Irfan J Lodhi; Susan E Logue; Bal L Lokeshwar; Yun Chau Long; Sagar Lonial; Benjamin Loos; Carlos López-Otín; Cristina López-Vicario; Mar Lorente; Philip L Lorenzi; Péter Lõrincz; Marek Los; Michael T Lotze; Penny E Lovat; Binfeng Lu; Bo Lu; Jiahong Lu; Qing Lu; She-Min Lu; Shuyan Lu; Yingying Lu; Frédéric Luciano; Shirley Luckhart; John Milton Lucocq; Paula Ludovico; Aurelia Lugea; Nicholas W Lukacs; Julian J Lum; Anders H Lund; Honglin Luo; Jia Luo; Shouqing Luo; Claudio Luparello; Timothy Lyons; Jianjie Ma; Yi Ma; Yong Ma; Zhenyi Ma; Juliano Machado; Glaucia M Machado-Santelli; Fernando Macian; Gustavo C MacIntosh; Jeffrey P MacKeigan; Kay F Macleod; John D MacMicking; Lee Ann MacMillan-Crow; Frank Madeo; Muniswamy Madesh; Julio Madrigal-Matute; Akiko Maeda; Tatsuya Maeda; Gustavo Maegawa; Emilia Maellaro; Hannelore Maes; Marta Magariños; Kenneth Maiese; Tapas K Maiti; Luigi Maiuri; Maria Chiara Maiuri; Carl G Maki; Roland Malli; Walter Malorni; Alina Maloyan; Fathia Mami-Chouaib; Na Man; Joseph D Mancias; Eva-Maria Mandelkow; Michael A Mandell; Angelo A Manfredi; Serge N Manié; Claudia Manzoni; Kai Mao; Zixu Mao; Zong-Wan Mao; Philippe Marambaud; Anna Maria Marconi; Zvonimir Marelja; Gabriella Marfe; Marta Margeta; Eva Margittai; Muriel Mari; Francesca V Mariani; Concepcio Marin; Sara Marinelli; Guillermo Mariño; Ivanka Markovic; Rebecca Marquez; Alberto M Martelli; Sascha Martens; Katie R Martin; Seamus J Martin; Shaun Martin; Miguel A Martin-Acebes; Paloma Martín-Sanz; Camille Martinand-Mari; Wim Martinet; Jennifer Martinez; Nuria Martinez-Lopez; Ubaldo Martinez-Outschoorn; Moisés Martínez-Velázquez; Marta Martinez-Vicente; Waleska Kerllen Martins; Hirosato Mashima; James A Mastrianni; Giuseppe Matarese; Paola Matarrese; Roberto Mateo; Satoaki Matoba; Naomichi Matsumoto; Takehiko Matsushita; Akira Matsuura; Takeshi Matsuzawa; Mark P Mattson; Soledad Matus; Norma Maugeri; Caroline Mauvezin; Andreas Mayer; Dusica Maysinger; Guillermo D Mazzolini; Mary Kate McBrayer; Kimberly McCall; Craig McCormick; Gerald M McInerney; Skye C McIver; Sharon McKenna; John J McMahon; Iain A McNeish; Fatima Mechta-Grigoriou; Jan Paul Medema; Diego L Medina; Klara Megyeri; Maryam Mehrpour; Jawahar L Mehta; Yide Mei; Ute-Christiane Meier; Alfred J Meijer; Alicia Meléndez; Gerry Melino; Sonia Melino; Edesio Jose Tenorio de Melo; Maria A Mena; Marc D Meneghini; Javier A Menendez; Regina Menezes; Liesu Meng; Ling-Hua Meng; Songshu Meng; Rossella Menghini; A Sue Menko; Rubem Fs Menna-Barreto; Manoj B Menon; Marco A Meraz-Ríos; Giuseppe Merla; Luciano Merlini; Angelica M Merlot; Andreas Meryk; Stefania Meschini; Joel N Meyer; Man-Tian Mi; Chao-Yu Miao; Lucia Micale; Simon Michaeli; Carine Michiels; Anna Rita Migliaccio; Anastasia Susie Mihailidou; Dalibor Mijaljica; Katsuhiko Mikoshiba; Enrico Milan; Leonor Miller-Fleming; Gordon B Mills; Ian G Mills; Georgia Minakaki; Berge A Minassian; Xiu-Fen Ming; Farida Minibayeva; Elena A Minina; Justine D Mintern; Saverio Minucci; Antonio Miranda-Vizuete; Claire H Mitchell; Shigeki Miyamoto; Keisuke Miyazawa; Noboru Mizushima; Katarzyna Mnich; Baharia Mograbi; Simin Mohseni; Luis Ferreira Moita; Marco Molinari; Maurizio Molinari; Andreas Buch Møller; Bertrand Mollereau; Faustino Mollinedo; Marco Mongillo; Martha M Monick; Serena Montagnaro; Craig Montell; Darren J Moore; Michael N Moore; Rodrigo Mora-Rodriguez; Paula I Moreira; Etienne Morel; Maria Beatrice Morelli; Sandra Moreno; Michael J Morgan; Arnaud Moris; Yuji Moriyasu; Janna L Morrison; Lynda A Morrison; Eugenia Morselli; Jorge Moscat; Pope L Moseley; Serge Mostowy; Elisa Motori; Denis Mottet; Jeremy C Mottram; Charbel E-H Moussa; Vassiliki E Mpakou; Hasan Mukhtar; Jean M Mulcahy Levy; Sylviane Muller; Raquel Muñoz-Moreno; Cristina Muñoz-Pinedo; Christian Münz; Maureen E Murphy; James T Murray; Aditya Murthy; Indira U Mysorekar; Ivan R Nabi; Massimo Nabissi; Gustavo A Nader; Yukitoshi Nagahara; Yoshitaka Nagai; Kazuhiro Nagata; Anika Nagelkerke; Péter Nagy; Samisubbu R Naidu; Sreejayan Nair; Hiroyasu Nakano; Hitoshi Nakatogawa; Meera Nanjundan; Gennaro Napolitano; Naweed I Naqvi; Roberta Nardacci; Derek P Narendra; Masashi Narita; Anna Chiara Nascimbeni; Ramesh Natarajan; Luiz C Navegantes; Steffan T Nawrocki; Taras Y Nazarko; Volodymyr Y Nazarko; Thomas Neill; Luca M Neri; Mihai G Netea; Romana T Netea-Maier; Bruno M Neves; Paul A Ney; Ioannis P Nezis; Hang Tt Nguyen; Huu Phuc Nguyen; Anne-Sophie Nicot; Hilde Nilsen; Per Nilsson; Mikio Nishimura; Ichizo Nishino; Mireia Niso-Santano; Hua Niu; Ralph A Nixon; Vincent Co Njar; Takeshi Noda; Angelika A Noegel; Elsie Magdalena Nolte; Erik Norberg; Koenraad K Norga; Sakineh Kazemi Noureini; Shoji Notomi; Lucia Notterpek; Karin Nowikovsky; Nobuyuki Nukina; Thorsten Nürnberger; Valerie B O'Donnell; Tracey O'Donovan; Peter J O'Dwyer; Ina Oehme; Clara L Oeste; Michinaga Ogawa; Besim Ogretmen; Yuji Ogura; Young J Oh; Masaki Ohmuraya; Takayuki Ohshima; Rani Ojha; Koji Okamoto; Toshiro Okazaki; F Javier Oliver; Karin Ollinger; Stefan Olsson; Daniel P Orban; Paulina Ordonez; Idil Orhon; Laszlo Orosz; Eyleen J O'Rourke; Helena Orozco; Angel L Ortega; Elena Ortona; Laura D Osellame; Junko Oshima; Shigeru Oshima; Heinz D Osiewacz; Takanobu Otomo; Kinya Otsu; Jing-Hsiung James Ou; Tiago F Outeiro; Dong-Yun Ouyang; Hongjiao Ouyang; Michael Overholtzer; Michelle A Ozbun; P Hande Ozdinler; Bulent Ozpolat; Consiglia Pacelli; Paolo Paganetti; Guylène Page; Gilles Pages; Ugo Pagnini; Beata Pajak; Stephen C Pak; Karolina Pakos-Zebrucka; Nazzy Pakpour; Zdena Palková; Francesca Palladino; Kathrin Pallauf; Nicolas Pallet; Marta Palmieri; Søren R Paludan; Camilla Palumbo; Silvia Palumbo; Olatz Pampliega; Hongming Pan; Wei Pan; Theocharis Panaretakis; Aseem Pandey; Areti Pantazopoulou; Zuzana Papackova; Daniela L Papademetrio; Issidora Papassideri; Alessio Papini; Nirmala Parajuli; Julian Pardo; Vrajesh V Parekh; Giancarlo Parenti; Jong-In Park; Junsoo Park; Ohkmae K Park; Roy Parker; Rosanna Parlato; Jan B Parys; Katherine R Parzych; Jean-Max Pasquet; Benoit Pasquier; Kishore Bs Pasumarthi; Daniel Patschan; Cam Patterson; Sophie Pattingre; Scott Pattison; Arnim Pause; Hermann Pavenstädt; Flaminia Pavone; Zully Pedrozo; Fernando J Peña; Miguel A Peñalva; Mario Pende; Jianxin Peng; Fabio Penna; Josef M Penninger; Anna Pensalfini; Salvatore Pepe; Gustavo Js Pereira; Paulo C Pereira; Verónica Pérez-de la Cruz; María Esther Pérez-Pérez; Diego Pérez-Rodríguez; Dolores Pérez-Sala; Celine Perier; Andras Perl; David H Perlmutter; Ida Perrotta; Shazib Pervaiz; Maija Pesonen; Jeffrey E Pessin; Godefridus J Peters; Morten Petersen; Irina Petrache; Basil J Petrof; Goran Petrovski; James M Phang; Mauro Piacentini; Marina Pierdominici; Philippe Pierre; Valérie Pierrefite-Carle; Federico Pietrocola; Felipe X Pimentel-Muiños; Mario Pinar; Benjamin Pineda; Ronit Pinkas-Kramarski; Marcello Pinti; Paolo Pinton; Bilal Piperdi; James M Piret; Leonidas C Platanias; Harald W Platta; Edward D Plowey; Stefanie Pöggeler; Marc Poirot; Peter Polčic; Angelo Poletti; Audrey H Poon; Hana Popelka; Blagovesta Popova; Izabela Poprawa; Shibu M Poulose; Joanna Poulton; Scott K Powers; Ted Powers; Mercedes Pozuelo-Rubio; Krisna Prak; Reinhild Prange; Mark Prescott; Muriel Priault; Sharon Prince; Richard L Proia; Tassula Proikas-Cezanne; Holger Prokisch; Vasilis J Promponas; Karin Przyklenk; Rosa Puertollano; Subbiah Pugazhenthi; Luigi Puglielli; Aurora Pujol; Julien Puyal; Dohun Pyeon; Xin Qi; Wen-Bin Qian; Zheng-Hong Qin; Yu Qiu; Ziwei Qu; Joe Quadrilatero; Frederick Quinn; Nina Raben; Hannah Rabinowich; Flavia Radogna; Michael J Ragusa; Mohamed Rahmani; Komal Raina; Sasanka Ramanadham; Rajagopal Ramesh; Abdelhaq Rami; Sarron Randall-Demllo; Felix Randow; Hai Rao; V Ashutosh Rao; Blake B Rasmussen; Tobias M Rasse; Edward A Ratovitski; Pierre-Emmanuel Rautou; Swapan K Ray; Babak Razani; Bruce H Reed; Fulvio Reggiori; Markus Rehm; Andreas S Reichert; Theo Rein; David J Reiner; Eric Reits; Jun Ren; Xingcong Ren; Maurizio Renna; Jane Eb Reusch; Jose L Revuelta; Leticia Reyes; Alireza R Rezaie; Robert I Richards; Des R Richardson; Clémence Richetta; Michael A Riehle; Bertrand H Rihn; Yasuko Rikihisa; Brigit E Riley; Gerald Rimbach; Maria Rita Rippo; Konstantinos Ritis; Federica Rizzi; Elizete Rizzo; Peter J Roach; Jeffrey Robbins; Michel Roberge; Gabriela Roca; Maria Carmela Roccheri; Sonia Rocha; Cecilia Mp Rodrigues; Clara I Rodríguez; Santiago Rodriguez de Cordoba; Natalia Rodriguez-Muela; Jeroen Roelofs; Vladimir V Rogov; Troy T Rohn; Bärbel Rohrer; Davide Romanelli; Luigina Romani; Patricia Silvia Romano; M Isabel G Roncero; Jose Luis Rosa; Alicia Rosello; Kirill V Rosen; Philip Rosenstiel; Magdalena Rost-Roszkowska; Kevin A Roth; Gael Roué; Mustapha Rouis; Kasper M Rouschop; Daniel T Ruan; Diego Ruano; David C Rubinsztein; Edmund B Rucker; Assaf Rudich; Emil Rudolf; Ruediger Rudolf; Markus A Ruegg; Carmen Ruiz-Roldan; Avnika Ashok Ruparelia; Paola Rusmini; David W Russ; Gian Luigi Russo; Giuseppe Russo; Rossella Russo; Tor Erik Rusten; Victoria Ryabovol; Kevin M Ryan; Stefan W Ryter; David M Sabatini; Michael Sacher; Carsten Sachse; Michael N Sack; Junichi Sadoshima; Paul Saftig; Ronit Sagi-Eisenberg; Sumit Sahni; Pothana Saikumar; Tsunenori Saito; Tatsuya Saitoh; Koichi Sakakura; Machiko Sakoh-Nakatogawa; Yasuhito Sakuraba; María Salazar-Roa; Paolo Salomoni; Ashok K Saluja; Paul M Salvaterra; Rosa Salvioli; Afshin Samali; Anthony Mj Sanchez; José A Sánchez-Alcázar; Ricardo Sanchez-Prieto; Marco Sandri; Miguel A Sanjuan; Stefano Santaguida; Laura Santambrogio; Giorgio Santoni; Claudia Nunes Dos Santos; Shweta Saran; Marco Sardiello; Graeme Sargent; Pallabi Sarkar; Sovan Sarkar; Maria Rosa Sarrias; Minnie M Sarwal; Chihiro Sasakawa; Motoko Sasaki; Miklos Sass; Ken Sato; Miyuki Sato; Joseph Satriano; Niramol Savaraj; Svetlana Saveljeva; Liliana Schaefer; Ulrich E Schaible; Michael Scharl; Hermann M Schatzl; Randy Schekman; Wiep Scheper; Alfonso Schiavi; Hyman M Schipper; Hana Schmeisser; Jens Schmidt; Ingo Schmitz; Bianca E Schneider; E Marion Schneider; Jaime L Schneider; Eric A Schon; Miriam J Schönenberger; Axel H Schönthal; Daniel F Schorderet; Bernd Schröder; Sebastian Schuck; Ryan J Schulze; Melanie Schwarten; Thomas L Schwarz; Sebastiano Sciarretta; Kathleen Scotto; A Ivana Scovassi; Robert A Screaton; Mark Screen; Hugo Seca; Simon Sedej; Laura Segatori; Nava Segev; Per O Seglen; Jose M Seguí-Simarro; Juan Segura-Aguilar; Ekihiro Seki; Christian Sell; Iban Seiliez; Clay F Semenkovich; Gregg L Semenza; Utpal Sen; Andreas L Serra; Ana Serrano-Puebla; Hiromi Sesaki; Takao Setoguchi; Carmine Settembre; John J Shacka; Ayesha N Shajahan-Haq; Irving M Shapiro; Shweta Sharma; Hua She; C-K James Shen; Chiung-Chyi Shen; Han-Ming Shen; Sanbing Shen; Weili Shen; Rui Sheng; Xianyong Sheng; Zu-Hang Sheng; Trevor G Shepherd; Junyan Shi; Qiang Shi; Qinghua Shi; Yuguang Shi; Shusaku Shibutani; Kenichi Shibuya; Yoshihiro Shidoji; Jeng-Jer Shieh; Chwen-Ming Shih; Yohta Shimada; Shigeomi Shimizu; Dong Wook Shin; Mari L Shinohara; Michiko Shintani; Takahiro Shintani; Tetsuo Shioi; Ken Shirabe; Ronit Shiri-Sverdlov; Orian Shirihai; Gordon C Shore; Chih-Wen Shu; Deepak Shukla; Andriy A Sibirny; Valentina Sica; Christina J Sigurdson; Einar M Sigurdsson; Puran Singh Sijwali; Beata Sikorska; Wilian A Silveira; Sandrine Silvente-Poirot; Gary A Silverman; Jan Simak; Thomas Simmet; Anna Katharina Simon; Hans-Uwe Simon; Cristiano Simone; Matias Simons; Anne Simonsen; Rajat Singh; Shivendra V Singh; Shrawan K Singh; Debasish Sinha; Sangita Sinha; Frank A Sinicrope; Agnieszka Sirko; Kapil Sirohi; Balindiwe Jn Sishi; Annie Sittler; Parco M Siu; Efthimios Sivridis; Anna Skwarska; Ruth Slack; Iva Slaninová; Nikolai Slavov; Soraya S Smaili; Keiran Sm Smalley; Duncan R Smith; Stefaan J Soenen; Scott A Soleimanpour; Anita Solhaug; Kumaravel Somasundaram; Jin H Son; Avinash Sonawane; Chunjuan Song; Fuyong Song; Hyun Kyu Song; Ju-Xian Song; Wei Song; Kai Y Soo; Anil K Sood; Tuck Wah Soong; Virawudh Soontornniyomkij; Maurizio Sorice; Federica Sotgia; David R Soto-Pantoja; Areechun Sotthibundhu; Maria João Sousa; Herman P Spaink; Paul N Span; Anne Spang; Janet D Sparks; Peter G Speck; Stephen A Spector; Claudia D Spies; Wolfdieter Springer; Daret St Clair; Alessandra Stacchiotti; Bart Staels; Michael T Stang; Daniel T Starczynowski; Petro Starokadomskyy; Clemens Steegborn; John W Steele; Leonidas Stefanis; Joan Steffan; Christine M Stellrecht; Harald Stenmark; Tomasz M Stepkowski; Stęphan T Stern; Craig Stevens; Brent R Stockwell; Veronika Stoka; Zuzana Storchova; Björn Stork; Vassilis Stratoulias; Dimitrios J Stravopodis; Pavel Strnad; Anne Marie Strohecker; Anna-Lena Ström; Per Stromhaug; Jiri Stulik; Yu-Xiong Su; Zhaoliang Su; Carlos S Subauste; Srinivasa Subramaniam; Carolyn M Sue; Sang Won Suh; Xinbing Sui; Supawadee Sukseree; David Sulzer; Fang-Lin Sun; Jiaren Sun; Jun Sun; Shi-Yong Sun; Yang Sun; Yi Sun; Yingjie Sun; Vinod Sundaramoorthy; Joseph Sung; Hidekazu Suzuki; Kuninori Suzuki; Naoki Suzuki; Tadashi Suzuki; Yuichiro J Suzuki; Michele S Swanson; Charles Swanton; Karl Swärd; Ghanshyam Swarup; Sean T Sweeney; Paul W Sylvester; Zsuzsanna Szatmari; Eva Szegezdi; Peter W Szlosarek; Heinrich Taegtmeyer; Marco Tafani; Emmanuel Taillebourg; Stephen Wg Tait; Krisztina Takacs-Vellai; Yoshinori Takahashi; Szabolcs Takáts; Genzou Takemura; Nagio Takigawa; Nicholas J Talbot; Elena Tamagno; Jerome Tamburini; Cai-Ping Tan; Lan Tan; Mei Lan Tan; Ming Tan; Yee-Joo Tan; Keiji Tanaka; Masaki Tanaka; Daolin Tang; Dingzhong Tang; Guomei Tang; Isei Tanida; Kunikazu Tanji; Bakhos A Tannous; Jose A Tapia; Inmaculada Tasset-Cuevas; Marc Tatar; Iman Tavassoly; Nektarios Tavernarakis; Allen Taylor; Graham S Taylor; Gregory A Taylor; J Paul Taylor; Mark J Taylor; Elena V Tchetina; Andrew R Tee; Fatima Teixeira-Clerc; Sucheta Telang; Tewin Tencomnao; Ba-Bie Teng; Ru-Jeng Teng; Faraj Terro; Gianluca Tettamanti; Arianne L Theiss; Anne E Theron; Kelly Jean Thomas; Marcos P Thomé; Paul G Thomes; Andrew Thorburn; Jeremy Thorner; Thomas Thum; Michael Thumm; Teresa Lm Thurston; Ling Tian; Andreas Till; Jenny Pan-Yun Ting; Vladimir I Titorenko; Lilach Toker; Stefano Toldo; Sharon A Tooze; Ivan Topisirovic; Maria Lyngaas Torgersen; Liliana Torosantucci; Alicia Torriglia; Maria Rosaria Torrisi; Cathy Tournier; Roberto Towns; Vladimir Trajkovic; Leonardo H Travassos; Gemma Triola; Durga Nand Tripathi; Daniela Trisciuoglio; Rodrigo Troncoso; Ioannis P Trougakos; Anita C Truttmann; Kuen-Jer Tsai; Mario P Tschan; Yi-Hsin Tseng; Takayuki Tsukuba; Allan Tsung; Andrey S Tsvetkov; Shuiping Tu; Hsing-Yu Tuan; Marco Tucci; David A Tumbarello; Boris Turk; Vito Turk; Robin Fb Turner; Anders A Tveita; Suresh C Tyagi; Makoto Ubukata; Yasuo Uchiyama; Andrej Udelnow; Takashi Ueno; Midori Umekawa; Rika Umemiya-Shirafuji; Benjamin R Underwood; Christian Ungermann; Rodrigo P Ureshino; Ryo Ushioda; Vladimir N Uversky; Néstor L Uzcátegui; Thomas Vaccari; Maria I Vaccaro; Libuše Váchová; Helin Vakifahmetoglu-Norberg; Rut Valdor; Enza Maria Valente; Francois Vallette; Angela M Valverde; Greet Van den Berghe; Ludo Van Den Bosch; Gijs R van den Brink; F Gisou van der Goot; Ida J van der Klei; Luc Jw van der Laan; Wouter G van Doorn; Marjolein van Egmond; Kenneth L van Golen; Luc Van Kaer; Menno van Lookeren Campagne; Peter Vandenabeele; Wim Vandenberghe; Ilse Vanhorebeek; Isabel Varela-Nieto; M Helena Vasconcelos; Radovan Vasko; Demetrios G Vavvas; Ignacio Vega-Naredo; Guillermo Velasco; Athanassios D Velentzas; Panagiotis D Velentzas; Tibor Vellai; Edo Vellenga; Mikkel Holm Vendelbo; Kartik Venkatachalam; Natascia Ventura; Salvador Ventura; Patrícia St Veras; Mireille Verdier; Beata G Vertessy; Andrea Viale; Michel Vidal; Helena L A Vieira; Richard D Vierstra; Nadarajah Vigneswaran; Neeraj Vij; Miquel Vila; Margarita Villar; Victor H Villar; Joan Villarroya; Cécile Vindis; Giampietro Viola; Maria Teresa Viscomi; Giovanni Vitale; Dan T Vogl; Olga V Voitsekhovskaja; Clarissa von Haefen; Karin von Schwarzenberg; Daniel E Voth; Valérie Vouret-Craviari; Kristina Vuori; Jatin M Vyas; Christian Waeber; Cheryl Lyn Walker; Mark J Walker; Jochen Walter; Lei Wan; Xiangbo Wan; Bo Wang; Caihong Wang; Chao-Yung Wang; Chengshu Wang; Chenran Wang; Chuangui Wang; Dong Wang; Fen Wang; Fuxin Wang; Guanghui Wang; Hai-Jie Wang; Haichao Wang; Hong-Gang Wang; Hongmin Wang; Horng-Dar Wang; Jing Wang; Junjun Wang; Mei Wang; Mei-Qing Wang; Pei-Yu Wang; Peng Wang; Richard C Wang; Shuo Wang; Ting-Fang Wang; Xian Wang; Xiao-Jia Wang; Xiao-Wei Wang; Xin Wang; Xuejun Wang; Yan Wang; Yanming Wang; Ying Wang; Ying-Jan Wang; Yipeng Wang; Yu Wang; Yu Tian Wang; Yuqing Wang; Zhi-Nong Wang; Pablo Wappner; Carl Ward; Diane McVey Ward; Gary Warnes; Hirotaka Watada; Yoshihisa Watanabe; Kei Watase; Timothy E Weaver; Colin D Weekes; Jiwu Wei; Thomas Weide; Conrad C Weihl; Günther Weindl; Simone Nardin Weis; Longping Wen; Xin Wen; Yunfei Wen; Benedikt Westermann; Cornelia M Weyand; Anthony R White; Eileen White; J Lindsay Whitton; Alexander J Whitworth; Joëlle Wiels; Franziska Wild; Manon E Wildenberg; Tom Wileman; Deepti Srinivas Wilkinson; Simon Wilkinson; Dieter Willbold; Chris Williams; Katherine Williams; Peter R Williamson; Konstanze F Winklhofer; Steven S Witkin; Stephanie E Wohlgemuth; Thomas Wollert; Ernst J Wolvetang; Esther Wong; G William Wong; Richard W Wong; Vincent Kam Wai Wong; Elizabeth A Woodcock; Karen L Wright; Chunlai Wu; Defeng Wu; Gen Sheng Wu; Jian Wu; Junfang Wu; Mian Wu; Min Wu; Shengzhou Wu; William Kk Wu; Yaohua Wu; Zhenlong Wu; Cristina Pr Xavier; Ramnik J Xavier; Gui-Xian Xia; Tian Xia; Weiliang Xia; Yong Xia; Hengyi Xiao; Jian Xiao; Shi Xiao; Wuhan Xiao; Chuan-Ming Xie; Zhiping Xie; Zhonglin Xie; Maria Xilouri; Yuyan Xiong; Chuanshan Xu; Congfeng Xu; Feng Xu; Haoxing Xu; Hongwei Xu; Jian Xu; Jianzhen Xu; Jinxian Xu; Liang Xu; Xiaolei Xu; Yangqing Xu; Ye Xu; Zhi-Xiang Xu; Ziheng Xu; Yu Xue; Takahiro Yamada; Ai Yamamoto; Koji Yamanaka; Shunhei Yamashina; Shigeko Yamashiro; Bing Yan; Bo Yan; Xianghua Yan; Zhen Yan; Yasuo Yanagi; Dun-Sheng Yang; Jin-Ming Yang; Liu Yang; Minghua Yang; Pei-Ming Yang; Peixin Yang; Qian Yang; Wannian Yang; Wei Yuan Yang; Xuesong Yang; Yi Yang; Ying Yang; Zhifen Yang; Zhihong Yang; Meng-Chao Yao; Pamela J Yao; Xiaofeng Yao; Zhenyu Yao; Zhiyuan Yao; Linda S Yasui; Mingxiang Ye; Barry Yedvobnick; Behzad Yeganeh; Elizabeth S Yeh; Patricia L Yeyati; Fan Yi; Long Yi; Xiao-Ming Yin; Calvin K Yip; Yeong-Min Yoo; Young Hyun Yoo; Seung-Yong Yoon; Ken-Ichi Yoshida; Tamotsu Yoshimori; Ken H Young; Huixin Yu; Jane J Yu; Jin-Tai Yu; Jun Yu; Li Yu; W Haung Yu; Xiao-Fang Yu; Zhengping Yu; Junying Yuan; Zhi-Min Yuan; Beatrice Yjt Yue; Jianbo Yue; Zhenyu Yue; David N Zacks; Eldad Zacksenhaus; Nadia Zaffaroni; Tania Zaglia; Zahra Zakeri; Vincent Zecchini; Jinsheng Zeng; Min Zeng; Qi Zeng; Antonis S Zervos; Donna D Zhang; Fan Zhang; Guo Zhang; Guo-Chang Zhang; Hao Zhang; Hong Zhang; Hong Zhang; Hongbing Zhang; Jian Zhang; Jian Zhang; Jiangwei Zhang; Jianhua Zhang; Jing-Pu Zhang; Li Zhang; Lin Zhang; Lin Zhang; Long Zhang; Ming-Yong Zhang; Xiangnan Zhang; Xu Dong Zhang; Yan Zhang; Yang Zhang; Yanjin Zhang; Yingmei Zhang; Yunjiao Zhang; Mei Zhao; Wei-Li Zhao; Xiaonan Zhao; Yan G Zhao; Ying Zhao; Yongchao Zhao; Yu-Xia Zhao; Zhendong Zhao; Zhizhuang J Zhao; Dexian Zheng; Xi-Long Zheng; Xiaoxiang Zheng; Boris Zhivotovsky; Qing Zhong; Guang-Zhou Zhou; Guofei Zhou; Huiping Zhou; Shu-Feng Zhou; Xu-Jie Zhou; Hongxin Zhu; Hua Zhu; Wei-Guo Zhu; Wenhua Zhu; Xiao-Feng Zhu; Yuhua Zhu; Shi-Mei Zhuang; Xiaohong Zhuang; Elio Ziparo; Christos E Zois; Teresa Zoladek; Wei-Xing Zong; Antonio Zorzano; Susu M Zughaier
Journal:  Autophagy       Date:  2016       Impact factor: 16.016

View more
  10 in total

1.  Extracellular histones induce inflammation and senescence of vascular smooth muscle cells by activating the AMPK/FOXO4 signaling pathway.

Authors:  Hang Yang; Yong-Yan Luo; Lue-Tao Zhang; Kai-Ran He; Xiao-Jun Lin
Journal:  Inflamm Res       Date:  2022-08-01       Impact factor: 6.986

Review 2.  The FOXO family of transcription factors: key molecular players in gastric cancer.

Authors:  Ying Liu; Xiang Ao; Yi Jia; Xiaoge Li; Yu Wang; Jianxun Wang
Journal:  J Mol Med (Berl)       Date:  2022-06-10       Impact factor: 5.606

3.  A Multi-Omics Study on the Effect of Helicobacter Pylori-Related Genes in the Tumor Immunity on Stomach Adenocarcinoma.

Authors:  Xinrui Wu; Aiwen Jian; Haidan Tang; Wangrui Liu; Fengyuan Liu; Shifan Liu; Huiqun Wu
Journal:  Front Cell Infect Microbiol       Date:  2022-05-10       Impact factor: 6.073

4.  Systems pharmacology to reveal multi-scale mechanisms of traditional Chinese medicine for gastric cancer.

Authors:  Lulu Zhang; Yue Xiao; Ruijie Yang; Siyi Wang; ShuangXin Ma; Jianling Liu; Wei Xiao; Yonghua Wang
Journal:  Sci Rep       Date:  2021-11-12       Impact factor: 4.379

Review 5.  Helicobacter pylori-Mediated Oxidative Stress and Gastric Diseases: A Review.

Authors:  Lu Han; Xu Shu; Jian Wang
Journal:  Front Microbiol       Date:  2022-02-08       Impact factor: 5.640

6.  Phycocyanin inhibits Helicobacter pylori-induced hyper-proliferation in AGS cells via activation of the ROS/MAPK signaling pathway.

Authors:  Yakun Bi; Daoyan Wu; Xiaojuan Wu; Fei Wang; Hang Yu; Pan Liu; Guzhen Cui; Zhenghong Chen
Journal:  Ann Transl Med       Date:  2022-02

Review 7.  An Overview of Autophagy in Helicobacter pylori Infection and Related Gastric Cancer.

Authors:  Yihan Yang; Xu Shu; Chuan Xie
Journal:  Front Cell Infect Microbiol       Date:  2022-04-08       Impact factor: 6.073

Review 8.  Performance of DNA Methylation on the Molecular Pathogenesis of Helicobacter pylori in Gastric Cancer; targeted therapy approach.

Authors:  Sogand Vahidi; Ebrahim Mirzajani; Seyedeh Elham Norollahi; Mohsen Aziminezhad; Ali Akbar Samadani
Journal:  J Pharmacopuncture       Date:  2022-06-30

9.  Vacuolating Cytotoxin A Triggers Mitophagy in Helicobacter pylori-Infected Human Gastric Epithelium Cells.

Authors:  Li Wang; Juan Yi; Xiao-Yang Yin; Jin-Xia Hou; Jing Chen; Bei Xie; Gang Chen; Qun-Feng Wang; Li-Na Wang; Xiao-Yuan Wang; Jing Sun; Lei-Ming Huo; Tuan-Jie Che; Hu-Lai Wei
Journal:  Front Oncol       Date:  2022-07-14       Impact factor: 5.738

Review 10.  Autophagy in gastrointestinal cancers.

Authors:  Bo-Zong Shao; Ning-Li Chai; Yi Yao; Jin-Ping Li; Helen Ka Wai Law; En-Qiang Linghu
Journal:  Front Oncol       Date:  2022-08-26       Impact factor: 5.738

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.